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Abstract 
Background: Nausea is a common and complex multi-system sensation however 
objective psychophysiological markers of nausea that also predict nausea susceptibility 
in humans are lacking. In addition, the regions of the brain that process the sensation of 
nausea are unknown.  
 
Aim: To investigate the brain processing of nausea in healthy individuals.  
 
Methods: Study 1 validated the visual motion induced nausea paradigm with autonomic 
measures. Study 2 preselected nausea susceptible versus nausea resistant subjects 
using the stimulus with autonomic, electrogastrographic and cortisol monitoring. Study 3 
investigated the brain processing of the nausea sensation and Study 4 identified which 
brain regions were specific to the generation of nausea.  
 
Results: Studies 1 and 2 – The stimulus was validated with stardardised questionnaires 
and identified nausea susceptible and resistant individuals with those susceptible 
demonstrating more anxiety; sympathetic arousal, parasympathetic withdrawal; shift 
from normogastria to dysrhythmia after motion video. Studies 3 and 4 – The inferior 
frontal gyrus was positively correlated with increasing nausea and the parahippocampus 
was inhibited. However, nausea resistant subjects demonstrated increased activity in 
the parahippocampus. The scopolamine study was overall inconclusive due to nausea 
being induced by the drug itself.  
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Conclusion: NS subjects decreased parasympathetics, normogastria and increased 
sympathetics, anxiety and gastric dysrhythmias suggesting these parameters could be 
used as markers of nausea susceptibility. The inferior frontal gyrus and 
parahippocampus appears to play a role in nausea genesis and should be investigated 
further in patients or with other nauseogenic stimulus, newer functional brain imaging 
modalities, as well as different pharmacological modulations 
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Nausea is a universal human experience and is associated with a range of 
psychological and physiological responses such as development of anxiety and 
changes in cardiac autonomic activity, gastric myoelectrical activity and neuroendocrinal 
hormones. While some knowledge of these psychophysiological responses associated 
with nausea exists, this information is largely through animal studies and preliminary 
human studies. In particular, there is a paucity of information available about the brain 
areas that are involved in the genesis of nausea sensation. There are a variety of novel 
methodologies for imaging brain function and investigating drug pharmacology (Borsook 
et al., 2006b) as well as for the induction of nausea by toxins e.g., ipecacuanha (Miller 
et al., 1996, Minton et al., 1993); and through the motion sickness pathway (Bijveld et 
al., 2008a). Kowalski (2006) have presented  possible approach to the study of nausea 
using functional brain imaging these include (i) adapting a safe nausea induction 
method (e.g. visual motion induced nausea), (ii) identifying subjects susceptible to the 
visual nausea induction and truly experience nausea but who can tolerate nausea 
without vomiting, (iii) investigation of  brain activity using functional magnetic resonance 
imaging (fMRI). 
The following sections will describe nausea, its importance and subsequently propose 
that fMRI studies are the way forward for nausea research. The current state of 
knowledge of nausea will be reviewed here and specific aspects reviewed in 
subsequent chapters. 
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1.1 Definitions 
Nausea is a sometimes difficult-to-describe thoroughly unpleasant sensation usually 
perceived as being in the stomach (Stern et al., 2011, Quigley et al., 2001) that exists 
on its own or may sometimes be followed by vomiting (Visser et al., 2001). Meanwhile, 
vomiting or emesis is the forceful evacuation of gastric contents through the mouth 
(Steele and Carlson, 2007). The challenge of studying nausea is that it is a dynamic 
sensation that is very difficult to define with wide variations in the way nausea is 
reported by each individual e.g. feeling sick, queasy, or butterflies in the stomach 
(Quigley et al., 2001, Gianaros et al., 2001). The “personal experience” of nausea that is 
different for every individual was well illustrated by Stern  et al., (2011) with his historical 
list of 30 different descriptions of nausea from the literature. It starts from Galen in the 
second century, “We also say that the living being becomes nauseous; that is, that the 
stomach starts to be emptied through vomiting”; and ends with the National Cancer 
Institute 2009, “Nausea is an unpleasant wavelike feeling in the back of the throat 
and/or stomach that may or may not result in vomiting”. 
In the context of this thesis, the definition of nausea will be the subjective report of 
nausea on a validated scale that is associated with some or all of the following: 
increasing levels of anxiety; sympathetic arousal and parasympathetic withdrawal; shift 
from normal gastric activity to abnormal activity; and also an increase in cortisol. 
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1.2 Assessing nausea 
The experience of nausea is a private sensation and difficult to describe or detect in 
another person as appearance alone does not reveal the sensation of nausea another 
human being is feeling (Stern et al., 2011). Thus, it is also not possible to be certain that 
the “nausea” experienced by one person is the same as another individual.  
If the observer is scientific and demands independent evidence before believing what a 
person is reporting (that is even assuming they are being truthful and can accurately 
describe their sensations), they are left with three methods: (1) asking the subject, 
preferably using a validated definition; (2) observing the subject’s behaviour; and (3) 
obtaining associated psychophysiological data. However, all three methods have 
limitations. In the chapters that follow in this thesis, it will be pointed out that changes in 
the autonomic nervous system (Chapter 2 and 3); plasma level of cortisol (Chapter 3); 
electrogastrogram (EGG) (Chapter 3); and central nervous system (Chapter 4 and 5) 
are all associated with the sensation of nausea. Appropriate changes measured in 
these associated markers of nausea would increase the likelihood that an experimenter 
could conclude that another individual was indeed experiencing nausea. 
 28 
 
1.3 Impact of nausea 
The socio-economic impact of nausea is considerable and it affects many patients and 
healthy individuals. In the United States, about 20,000 adults with upper gastrointestinal 
(GI) disorders were surveyed and nausea was present in 12% of females and 7% of 
males (Camilleri et al., 2005). The impact of nausea will be explored in a few clinical 
settings below however as nausea affects so many different conditions, its actual impact 
is very much larger. About 95% of pregnant women experience nausea during their 
pregnancy leading to 8.5 million lost working days annually in UK (Gadsby, 1994, 
Gadsby et al., 1993). It was also reported that post-operative nausea and vomiting was 
the main reason behind the delayed discharge from hospital of most high-risk patients 
who had undergone surgery (Fortier et al., 1998) and the costs of caring for such 
patients were an additional $415 per patient (Gadsby et al., 1993). In addition, it was 
estimated that nausea and vomiting costs the U.S. economy around 4 and 10 billion 
dollars per year (Blum et al., 2000). Nausea also impairs the quality of life of affected 
individuals (Grunberg et al., 1996).  
The 2009 European Society of Medical Oncology (ESMO) and the Multinational 
Association of Supportive Care in Cancer (MASCC) Consensus Conference on 
antiemetics concluded that the control of vomiting has markedly improved during the 
last years and therefore attention should shift to control of nausea, at present the 
greatest remaining emetogenic challenge (Roila et al., 2010).  
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1.4 Nausea the neglected symptom 
Nausea (currently number one fear for cancer patients (Ritter et al., 1998) is typically 
poorly treated with current management, is more commonly reported than vomiting, and 
nausea lasts longer and causes more distress overall in comparison to vomiting (Blum 
et al., 2000). However, most published human (Foubert and Vaessen, 2005) and animal 
studies of nausea and vomiting have not only reported nausea and vomiting as points 
on the same continuum of emesis but also mostly ignored the more common and more 
troublesome symptom of nausea in favour of vomiting leading to our current paucity of 
knowledge regarding nausea and its possible treatments (Stern et al., 2011). This is 
also partly due to the lack of a good animal model of nausea even though we have good 
animal models for vomiting and animal models like the ferret have played pivotal roles in 
identification of the anti-emetic effects of 5-hydroxytryptamine3 (5-HT3) and neurokinin1 
(NK1) receptor antagonists (Andrews and Horn, 2006, Sanger and Andrews, 2006). 
In humans, nausea can be more aversive than pain (Pelchat and Rozin, 1982) or 
vomiting (Morrow et al., 2002b) but is largely neglected due no validated objective 
markers (Andrews and Horn, 2006, Holmes et al., 2009).  In animals, which are unable 
even to articulate the experience of nausea, the situation is even more critical.  Indeed, 
the experience of nausea and vomiting has so far been an underestimated welfare 
issue in animal research and in safety studies for new medicines the issue of nausea is 
not automatically considered (Harrison et al., 1972, Holmes et al., 2009).  The result is a 
paucity of advances in the nausea research area in general. 
 30 
 
1.5 Pathways of nausea and vomiting 
Traditionally the three inputs inducing nausea and vomiting are the vestibular system 
via the vestibular nuclei, the area postrema, and the abdominal and cardiac vagal 
afferents, which all converge in the nucleus tracti solitarii (NTS) in the brainstem. This is 
where vomiting likely diverges from nausea with vomiting pathways confined to the 
brain stem as retching and vomiting (including prodomata like salivation, swallowing and 
licking) can be activated in decerebrate dogs, cats, ferrets and Suncus (Stern et al., 
2011). Meanwhile, the sensation of nausea involves the projection of information 
rostrally from the brainstem to the forebrain with the vomiting centre integrating vomiting 
signal and coordinating motor output (Andrews and Horn, 2006). 
The vomiting reflex is triggered by activation of the vomiting centre (an inter-related 
network of neurons rather than a definite anatomical site, first described by (Borison and 
Wang, 1953) in the medulla oblongata. This involves a complex interaction of receptors 
and neurotransmitters that are targets of anti-emetic therapy and they include 
histamine, acetylcholine, dopamine, noradrenaline, adrenaline, 5-hydroxytryptamine 
and substance P (Lang, 1990, Miller and Leslie, 1994). Vomiting efferent signals are 
carried via rostral ventrolateral medulla, dorsal vagal motor nucleus, nucleus 
ambiguous, superior and inferior salivatory nuclei, retrofacial nucleus and ventral 
respiratory group. These signals produce the complex coordinated set of autonomic 
responses, muscular contractions and reverse peristalsis seen in vomiting (Lang, 1990, 
Miller and Leslie, 1994).   
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1.5.1 Potential cortical pathways of nausea 
With few functional brain imaging studies exploring how and where nausea is 
generated, we can only draw on animal (primarily of rat (lacking an ability to vomit), cat, 
dog, and to a lesser extent the ferret and nonhuman primates) and human studies of 
processing visceral and vestibular information and studies of neural pathways of 
conditioned taste aversion in animals, which has been argued to be similar with nausea 
(see Andrews  2006 for a detailed review). Comparative studies of fundamental 
sensations (pain, hunger, and satiety) have identified common features of the 
processing pathways and as nausea is likely the same then there should be some 
common features in processing between species where nausea or analogous 
sensations are present. However, this must be done with the awareness that cerebral 
cortical anatomy between primates, cetaceans, and other mammals do vary (Craig, 
2009b, Craig, 2009a, Dunbar and Shultz, 2007, Marino, 2007, Butler et al., 1996, Craig, 
2002).  
The vestibular system (crucial for generating visual motion induced nausea (Yates et 
al., 1998) has projections to the vestibular nuclei and dorsal vagal complex to induce 
vomiting and its accompanying autonomic changes. There are also direct projections to 
the cerebellum, spinal cord, and to the extraocular muscles for somatomotor control, 
postural adjustments to head and neck muscles and limb extensor muscles, and to 
coordinate the movements of the eyes with those of the head respectively (Felten and 
Józefowicz, 2003). Thus the vestibular nuclei afferents to the temporoparietal cortex, 
lateral postcentral gyrus, insular cortex, and thalamus (posterolateral thalamus) may 
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show that higher cortical regions are likely involved in the genesis of the conscious 
sensation of nausea. 
In a magnetic source imaging study combining magnetoencephalography and MRI 
structural imaging, nausea induced by head movement during yaw-axis rotation 
increased activity in the inferior frontal gyrus that was not seen during speech, finger 
movement, exaggerated breathing or at baseline (Miller et al., 1996). Neuronal 
activation was also related to the intensity of nausea. The same subject when 
administered ipecac reported nausea with inferior frontal gyrus activation again that was 
reversed by 5-HT3 receptor antagonist (ondansetron). Further exploration is warranted 
with larger studies utilising newer technology like fMRI and also with stimuli that can be 
used routinely in the fMRI environment. 
Napadow et al (2012b) utilised newer technology to demonstrate that visual motion 
induced nausea may potentially be used to study nausea mechanisms in fMRI by using 
a specially designed head coil to present a visual stimulus of alternating black and white 
stripes with left-to-right circular motion simulating the rotating optokinetic drum to 29 
women. There was primary and extrastriate visual cortical activation with the stimulus in 
all subjects. Increasing nausea was associated with increasing activation in insular, 
anterior cingulate, orbitofrontal, somatosensory and prefrontal cortices. Moreover, a 
closer linkage between the anterior insula and midcingulate within the brain areas 
potentially involved in nausea perception was suggested with anterior insula activation 
correlating with midcingulate activation (r = 0.87). They also showed susceptible 
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subjects experiencing motion sickness had increasing phasic activity preceding nausea 
in the amygdala, putamen, and dorsal pons/locus ceruleus. In summary, phasic 
activations in fear conditioning and brainstem regions may precipitate transition to 
strong nausea. The multiple dimensions of visual motion induced nausea were then 
seen with activation of a broader network involving the interoceptive, limbic, 
somatosensory, and cognitive regions. Unfortunately, his study only utilised female 
subjects and there was no mention of controlling for their menstrual cycle. The 
associated psychophysiological correlates of nausea were also not studied and only 
subjective reports of nausea were used. Furthermore, individual variations were not 
controlled for with a control stimulus in these studies. In addition, an expensive specially 
fabricated head coil that was necessary for the stimulus which makes it impractical for 
other laboratories (verbal communication with a co-author, Professor Braden Kuo). 
It is worth noting the inferior frontal gyrus was also activated by galvanic vestibular 
stimulation (Bense et al., 2001, Stephan et al., 2005) caloric vestibular stimulation e.g., 
(Fasold et al., 2002) in human fMRI studies. The descending vestibular pathways from 
the semicircular canals and the otoliths to the dorsal vagal complex activate pathways 
ascending from the brain stem (Yates et al., 1998). Human fMRI galvanic (Bense et al., 
2001, Stephan et al., 2005) or caloric (Fasold et al., 2002) vestibular stimulation studies 
observed sensations of motion or nystagmus in the subjects as a side effect without any 
nausea. Galvanic stimulation, activates the basal ganglia, inferior and middle frontal 
gyrus, parahippocampal gyrus and hippocampus, cerebellum (crus I, vermal lobule IV), 
anterior and posterior insula and retroinsular regions (interoception and visceral 
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autonomic response), superior temporal gyrus, temporoparietal cortex, precentral gyrus, 
thalamus, anterior cingulate gyrus, and the supplementary motor area (Bense et al., 
2001, Stephan et al., 2005). 
Unpleasant odours (like hydrogen sulphide “rotten egg” smell) and bitter taste (Peyrot 
des Gachons et al., 2011) may also be used to study nausea but there may be 
difficulties in separating direct pathway (cf. olfactory, area postrema, vagal afferents) 
versus learned association induction of nausea. Hospital smells evoking vivid memories 
of the nausea and vomiting experienced during chemotherapy given at the same time is 
an example of learned association in anticipatory nausea and vomiting during 
anticancer chemotherapy (Morrow et al., 2002a). Brain imaging studies exploring real 
and imagined pleasant (strawberry) and unpleasant (rotten eggs) odours had increased 
activity in the left frontal piriform cortex (primary olfactory cortex) and the left insula, 
although activity was also increased in the orbitofrontal cortex in response to the real or 
imagined unpleasant odour (Bensafi et al., 2007). The pathways involved with 
unpleasant odours may be more complicated though as there are food in many cultures 
which smells like vomit (e.g. rancid, acidic, fermented) but are nevertheless eaten, 
indicating that the revulsion to certain odours can be suppressed probably by 
observation of conspecifics behaviours (usually parents). These odours have had so 
much notoriety that airlines in Southeast Asia are reported to have prominent signs to 
prevent the locally popular Durian fruit (Durio zibethinus) being brought into the cabin as 
when ripe is said to have an odour like stale vomit (Davidson, 1999). Bitter taste has a 
rational link to nausea because most plant-derived toxins taste bitter and causes 
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nausea in toxin-induced illness (Peyrot des Gachons et al., 2011) and it has been 
described that people who are the most sensitive to bitter stimuli are more prone to 
motion sickness (Benson et al., 2012, Sharma et al., 2008). A functional near-infrared 
spectroscopy with 6-n-propylthiouracil (bitter tasting) and salt presented to 48 healthy 
volunteers showed subjects perceiving bitter taste compared with those who don't 
increased left posterior dorsolateral prefrontal cortex and bilateral ventrolateral 
prefrontal cortex activity (Bembich et al., 2010). 
We may be able to also look at the more readily available information from visceral 
afferent studies of cortical projections to gain an insight into the nausea pathway(s) with 
suggestions that the brainstem afferent signals likely evoke a conscious sensation in the 
cerebrum, which may be interpreted as nausea but this is still being explored with 
evidence mostly from animal studies and some limited human studies discussed below. 
On top of that, descending modulation (periaqueductal gray, PAG), anticipation and 
attention during aversive stimuli (Van Oudenhove et al., 2007) like those seen in human 
pain pathways studies may also be present in nausea. 
Rat electrophysiological studies show vagal afferents going to the primary 
somatosensory cortex (S1) but in the cat they went to cortical area 3a but not 3b (S1 
equivalent) (Ito and Craig, 2003). The 3a, the cingulate, and insular cortex may make up 
a “visceral afferent cortical network” (Ito and Craig, 2003) and brain imaging studies in 
humans support the cat data discussed later. In addition, the insular cortex gets afferent 
projections from the basolateral amygdaloid nucleus and the infralimbic cortex (Loewy 
 36 
 
and Spyer, 1990) and initiate and modulate autonomic outflows via efferents to the 
amygdala, hypothalamus, PAG, and brainstem. Electrical stimulation of the 
hippocampus, the nucleus ventralis anterior of the thalamus, anterior perforated area, 
and the amygdala reliably induced vomiting in macaque monkeys (Robinson and 
Mishkin, 1968). Thus, animal studies show that projections from the brain stem (NTS 
and parabrachial nucleus, PBN) go to the insular cortex via routes encompassing the 
ventroposterior parvicellular thalamic nucleus (VPpc) or the hypothalamus (see Stern 
2011 for more detailed reviews of animal studies).  
Human brain gut pathway studies where nausea is not the primary outcome measure 
may still give us a preliminary idea of the visceral afferents pathways involved (Stephan 
et al., 2003, Aziz et al., 2000, Kern and Shaker, 2002, Derbyshire, 2003, Stephan et al., 
2005, Dunckley et al., 2005, Lawal et al., 2005, Vandenbergh et al., 2005, Coen et al., 
2007, Ladabaum et al., 2007). However there are relatively few stomach stimulation 
studies (structures commonly associated with nausea induction) with most brain 
imaging studies investigating either oesophageal or rectal painful and non-painful 
distension. 
In general, the same major nuclei like the parabrachial nucleus, hypothalamus, 
thalamus, cingulate cortex, and insular cortex are involved in visceral afferent 
processing in humans as discussed above in animals. The insula, interoceptive cortex, 
is the major cortical site to which visceral afferent (including vagal) information projects 
as seen in animal studies and human studies (oesophageal and gastric distension) 
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including studies (Aziz et al., 2000, Stephan et al., 2003, Stephan et al., 2005, 
Vandenbergh et al., 2005, Ladabaum et al., 2007) . In addition, thalamic projections are 
seen in humans to SI/SII somatosensory cortices, cingulate cortex (limbic motor cortex), 
insular cortex (limbic sensory cortex), prefrontal cortex (orbitofrontal cortex, dorsolateral 
prefrontal cortex) that are responsible for sensory, emotional, and cognitive responses 
to painful visceral stimulation in varying degrees (Coen et al., 2007). These areas of the 
brain have been collectively refered to as the cortical “visceral sensory/ pain 
neuromatrix” (Van Oudenhove et al., 2007). 
Studies stimulating the stomach that may be more associated with nausea induction 
include a PET study (Ladabaum et al., 2001) where progressive distal stomach 
distension in healthy volunteers showed activation in the caudate nucleus, anterior 
cingulate cortex, thalamus, and insula but was not symptom specific because there was 
strong correlation among the sensations(earlier related study provoked a gradation of 
bloating, pain, and nausea sensations (Ladabaum et al., 1998). Another fMRI study with 
painful fundic distension increased activity in the insular cortex, anterior and posterior 
cingulate cortex, right frontal lobe, and the inferior parietal lobes of the brain (Ladabaum 
et al., 2007). This is similar to results from fundic distension brain imaging studies with 
the caveat being primary somatosensory cortex (S1) activation (Vandenbergh et al., 
2005, Lu et al., 2004, Ladabaum et al., 2007).  
The development of a new treatment for standard therapy resistant epilepsy and 
depression using electrical stimulation of the vagus nerve has proven fortuitous for brain 
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imaging studies investigating the vagal pathway. (Dietrich et al., 2008) utilised fMRI and 
transcutaneous stimulation of the left cervical vagus to show involvement of the left 
locus coeruleus, left prefrontal cortex, bilaterally in the postcentral gyrus, left posterior 
cingulate gyrus, thalamus, and the left insula with vagal stimulation.   (Narayanan et al., 
2002) used implanted electrodes with similar results except for more insular and 
thalamic activation. (Kraus et al., 2007) also used fMRI and transcutaneous stimulation 
of the vagus nerve (auricular branch) with increased activation in the insula, precentral 
gyrus, and thalamus. What may possibly be equally important are areas deactivated by 
vagal stimulation that includes the hippocampus, parahippocampal gyrus, amygdala, 
superior temporal gyrus (Kraus et al., 2007), cerebellum, nucleus accumbens, and 
posterior cingulate gyrus (Henry et al., 1998, Dietrich et al., 2008). 
In summary, there are anatomical pathways by which nausea (and vomiting) signals 
can access the highest level of the brain where we assume they enter our 
consciousness (Figure 1). This provides a theoretical framework for nausea generation 
that we can utilise to design future studies investigating the cortical pathways involved 
in nausea.  
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Figure 1. Diagram summarizing major pathway(s) involved in the sensation of nausea. 
The pathways shown combine Craig’s (2002) primate pathways involved in the 
processing of abdominal vagal afferent information; and projections of the area 
postrema and vestibular system (Loewy and Spyer, 1990, Yates et al., 1998, Saper, 
2002) thus providing a pathway by which nausea could be induced by their activation. It 
also highlights the hierarchical information processing by shading brain structures with 
specific structures indicated with a dotted line (...). Second order projections with a 
dashed line (---) and higher order projections with a solid (__) line. Abbreviations: ANS-
Autonomic Nervous System; AP-Area Postrema; BS-Brain Stem; H-Hypothalamus 
(particularly Posterior hypothalamus, supraoptic and paraventricular nuclei); I-Insular 
region of the Cerebral Cortex; NTS-Nucleus Tractus Solitarius; PO- Pons; Sa – Greater 
Splanchnic Nerve Afferent Fibres; SC-Spinal Cord; T-Thalamus; Va-Abdominal Vagal 
Afferent Nerves; Vestibular n.-Vestibular Nerve Nucleus; VII-Vestibular Nerve; VMb-The 
basal region of the ventromedial thalamic nucleus; Vmpo-The posterior region of the 
ventromedial nucleus of the thalamus (Stern et al., 2011)   
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1.6 Aims 
The primary aim of my study was i) to develop a stimulus which could be reliably used 
to evoke nausea in preselected subjects (with their nauseous response validated by 
well-defined psychophysiological measurements), ii) to use this stimulus for a functional 
magnetic resonance imaging (fMRI) study to identify the brain processing of nausea, 
and iii) to compare brain activity in visual motion induced nausea susceptible and 
resistant subjects and iv) to perform pharmacological studies to determine that brain 
areas identified in the above studies were specific to the generation of nausea. 
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1 Introduction 
In identifying a suitable stimulus to study nausea without vomiting in healthy human 
volunteers, it is important to consider the safety aspects of the stimulus especially since 
during fMRI studies the subjects will be supine and will need to be able to easily stop 
the stimulus if necessary and investigators need a gradually increasing severity of the 
stimulus to have enough warning to prevent volunteers from vomiting. 
 
1.1 The challenge of studying nausea in humans 
The challenge of studying nausea is that it is a dynamic sensation that is very difficult to 
define (discussed in chapter 1) with wide variations in the way nausea is reported by 
each individual e.g. feeling sick, queasy, or butterflies in the stomach (Quigley et al., 
2001, Gianaros et al., 2001, Stern et al., 2011). In addition, there may also be 
associated symptoms of anxiety and autonomic changes e.g. feeling sweaty, warm, 
having tachycardia or stomach awareness.  
Furthermore, as currently available anti-emetics can be ineffective against nausea, an 
improved understanding of the pathways unique to nausea will be important in 
developing pharmacological agents potent against both nausea and vomiting 
(Herrington et al., 2000, Warr et al., 2005). 
The fact that the sensation of nausea represents a complex multi-system overlap of 
psychological and physiological aspects (Holmes et al., 2009, Morrow et al., 2002b) and 
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therefore necessitates a comprehensive investigation of all potential 
psychophysiological measures to fully understand their integration and interaction 
during the experience of nausea. Visual motion induced nausea provoking the typical 
psychophysiological markers will allow the identification of subjects who are suitable 
functional brain imaging studies of nausea genesis (Stern et al., 2011). 
The advent of new investigative modalities such as magnetic resonance imaging (MRI), 
positron emission tomography (PET) and computed tomography (CT) have 
revolutionized medicine as we now have noninvasive tools for exploring the structural 
and functional neuroanatomy of the human brain. In addition, other noninvasive 
methods are now available that allow measurement of outputs from the brain to the 
body e.g. novel measurements of brain stem mediated beat to beat variations in heart 
rate and vagal influence on the stomach muscle electrical activity. Furthermore, blood 
sampling can reveal neurohumoral pathway activity from the brain e.g. cortisol. 
Prediction of nausea susceptibility of individuals is important in many situations and not 
least among aviation trainees. Various motion sickness susceptibility questionnaires 
(MSSQ) have shown some reliability in predicting individual susceptibility (Golding, 
1998). However, they are subject to bias of recall of previous experiences of visually 
induced motion sickness. A negative history of visually induced motion sickness may be 
the result of non-encounter with a particular type of motion, lack of recent travel 
opportunity, reduction in susceptibility with age or lifestyle choice of avoidance 
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behaviour. Studies to comprehensively define objective biomarkers that accurately 
predict visually induced motion sickness are necessary. 
 
1.2 Methods of studying nausea. 
The first recorded study of nausea may be by Hippocrates two thousand years ago 
when he wrote ‘… sailing on the sea proves that motion disorders the body….’ following 
his observation of sailors at sea (Golding, 2006). The origin of the word ‘nausea’ from 
the Greek word ‘naus’ meaning ship may have been formulated from this observation. 
Following that, there have been many attempts at studying the nausea sensation in 
humans using various methods. 
 
1.2.1 Ingested or injected agents 
Nausea induction using ingested agents e.g. ipecac are effective in humans (Miller et 
al., 1996) however individual dosage variations to achieve similar levels of nausea and 
risk of complications are high (Schofferman, 1976), Intragastric irritants such as ipecac, 
and copper sulphate which cause nausea by stimulating abdominal vagal afferents have 
also been used as stimuli in nausea studies (Sanger and Andrews, 2006, Andrews and 
Horn, 2006). Other than that, systemic agents including cytotoxic drugs like cisplatin 
have been used for chemotherapy patients. There are also absorbed agents (including 
drugs) acting directly on the area postrema e.g. apomorphine, and morphine that have 
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been utilised in nausea and vomiting research (Andrews and Horn, 2006, Morrow, 
1985). They are difficult to control and risk of toxicity is often a major concern.  
 
1.3 Optokinetic drum for motion induced nausea 
Motion (both real and illusory) provides a stimulus that is relatively easy to control and 
subjects have complete control in the case of illusory motion that allows for a good 
safety profile which is important in fMRI studies when the subjects are lying down (Stern 
et al., 2011). Visual motion induced nausea provides a unique setting for the laboratory 
study of nausea, because of the observation that persons who are more susceptible are 
similarly more susceptible to nausea and vomiting from post-operative nausea and 
vomiting (Morrow, 1985). Laboratory simulation of these have employed means such 
physical body rotation and the phenomenon of vection (Bonato et al., 2005, Lackner 
and Dizio, 2006). A revolving chair study investigated the effects of placebo, 
dimenhydrinate (an antihistamine), and ginger root capsules on gastrointestinal 
sensations (Mowrey and Clayson, 1982). This psychophysical study reveals the 
temporal change in the intensity of gastrointestinal sensations and possibly shows the 
transition from nausea sensory pathways activation to vomiting or its prodromata. 
Various studies have since used the principles of vection for visual motion induced 
sickness using an optokinetic drum (Oman, 1998), (Figure 2). Visual field moves in 
opposite directions during motion and vection is the compelling illusion of self-motion in 
the opposite direction when a stationary individual observes movement in a large part of 
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their field of view (Kennedy et al., 1996). This visual input causes visual motion induced 
sickness on its own (Bubka and Bonato, 2003) likely due to conflicting stimuli from 
visual, vestibular and somatosensory systems as suggested by the sensory conflict 
theory (Oman, 1998, Reason, 1978), Although the optokinetic drum is effective in 
inducing nausea and vomiting but the large and moving metallic structures needed 
interferes with monitoring equipments and is unsuitable for functional magnetic 
resonance imaging (fMRI).  
Thus a virtual reality projected visual stimulus was developed that was validated against 
real motion (Bijveld et al., 2008b). With no moving parts and as it is adaptable to 
projectors already incorporated in standard MRI machines, it is deemed to be the most 
suitable stimulus available currently to study nausea without vomiting in humans (Figure 
3). 
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Figure 2. Optokinetic Drum. Subject is in a stationary seat within a painted drum with 
alternating black and white strips. Subject experiences illusory self-motion opposite to 
perceived visual motion with rotation of the drum leading to sensory mismatches 
between the visual, vestibular and kinaesthetic inputs, ultimately causing nausea and 
vomiting (Image source:http://www.opt.uab.edu, retrieved 8th August 2012). 
 48 
 
 
Figure 3. The novel stimulus - projected in front of a subject with goggles to limit their 
peripheral vision to the stimulus.  The off-vertical tilt helps create an illusion that the 
subject was actually spinning, at an angle which is found to hasten the onset of MSIN 
(Bijveld et al., 2008b) 
 
1.4 Knowledge gap 
Although the motion video has been validated to be an effective stimulus that’s similar 
to real physical motion (Bijveld et al., 2008b) the motion video has not been validated to 
effectively provoke the related psychophysiological changes. Studies using similar 
motion videos have generally been effective in provoking physiological changes like 
autonomic responses to nausea however there are also conflicting results especially 
when the subjective nausea report was of a mild level (Himi et al., 2004). 
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1.5 Research aims and hypothesis 
The aim of this study was to validate a human model of nausea without vomiting using 
the visual motion induced nausea method and to determine the psychophysiological 
changes associated with the development of nausea.  
By using the visual motion induced nausea model we can induce nausea in significant 
proportion of the study population and the induced nausea will be associated with 
objective changes in the autonomic responses which will act as markers for nausea 
perception.   
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2 Methods 
2.1 Study design and setting 
This was a randomised crossover pilot study i.e. the same subject is exposed to both a 
control and experimental condition. It was carried out at the Wingate Institute of 
Neurogatroenterology, Queen Mary University of London (QMUL). 
 
2.2.Ethical approval 
The Queen Mary University of London Research Ethics Committee (QMREC2008/37) 
approved these studies. 
 
2.3 Subjects 
Twenty healthy volunteers were recruited. All subjects signed a written informed 
consent. Volunteers were recruited to meet the following criteria: (i) normal body mass 
index, (ii) no abnormality on clinical examination, including a history or presence of 
cardiac, ophthalmologic, gastro-intestinal, hepatic, or renal disease, or other condition 
known to alter their response to visually induced motion sickness nausea e.g. vestibular 
disease, (iii) no abnormality on electrocardiogram examination at screening (iv) no 
abuse of alcohol (defined as an average intake >21 (male) or >14 (female) units per 
week or 3 units per day); and (v) no history or presence of neurological or psychiatric 
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conditions (e.g. stroke, traumatic brain injury, epilepsy, space-occupying lesions, 
multiple sclerosis, Parkinson’s disease, vascular dementia, transient ischaemic attack, 
schizophrenia, major depression, etc) (vi) females during their follicular phase of their 
menstrual cycle. Subjects with any of the following were excluded: (i) received 
prescribed medication within 14 days prior to the first visit, which might interfere with the 
study procedures or compromise safety, (ii) received over-the-counter medicine within 
48h before the scanning days, (iii) participated in a trial with any drug within 3 months 
before the first visit, (iv) had a caffeinated drink within 24 hours of visit. 
 
2.4 Materials and Protocol 
Subjects arrived at the institute following a fast of at least six hours. They subsequently 
underwent the experiment according to the protocol summarised in Figure 4. 
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Figure 4. Schematic summary of chapter 2 experimental protocol: After 6 hours of 
fasting subjects arrived for the study and answered questionnaires which e.g. assess 
motion sickness sensations and anxiety, reassessed just before starting motion or 
control video during which minute to minute nausea and anxiety scores were assessed 
using a VAS and another MSAQ and STAI-S questionnaire done at the end of the 
video. There were continuous monitoring of cardiac autonomic activity throughout.  
 
2.4.1 Psychometrics and motion sickness susceptibility questionnaires 
Validated questionnaires were used to assess different aspects of the psychological 
states and susceptibility to motion sickness of subjects. Psychometric data was 
analysed by summing individual responses (using formulae provided with each tool) and 
interpreting the derived sum from excel macro tables provided with a particular tool. 
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2.4.2 Big five inventory 
It is known that the usefulness of the NEO-personality inventory (NEO-PI) has been 
limited due to the large number of items that it contains (240 items), and the big five 
inventory (BFI) was developed to facilitate the rapid and flexible assessment of McCrae 
and Costa’s five dimensions of personality (McCrae RR, 2003). BFI contains only 44 
items, where the respondent agrees or disagrees with a series of statements on a five-
point Likert scale. It has been demonstrated that the BFI has substantial reliability and 
validity and has excellent concordance with the NEO-PI (Soto et al., 2008). The BFI is 
widely available in the public domain. 
 
2.4.3 Spielberger State and Trait Anxiety Inventory 
The Spielberger state and trait anxiety inventory (STAI) is a commonly used instrument 
for measuring transient and enduring levels of anxiety, respectively (CD, 1983).. The 
STAI (each scale contains 20 items scored on a four-point Likert scale) has been 
validated with good test-retest reliability (Rule and Traver, 1983).  
 
2.4.4 Weinberger Adjustment Inventory 
The Weinberger adjustment inventory (WAI) is an assessment to measure self-restraint 
and overall adjustment. It consists of four subscales for Self-Restraint: impulse control, 
suppression of aggression, consideration of others, and responsibility; and four 
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subscales for Distress: :anxiety and depression, low self-esteem and low well-
being.(Weinberger et al., 1979). Along with these subscales are the measures of self-
deception, which is based on the hypothesis that people who deny having negative 
thoughts and feelings are self-deceptive. In essence, this produces a self-deception or 
“lie” score and is useful in excluding individuals are responding to self-report 
questionnaires in a biased manner.  
 
2.4.5 Hospital Anxiety Depression Scale 
The hospital anxiety depression scale (HADS) a research and clinical tool which is used 
extensively to provide clinicians with a reliable, valid and practical tool for anxiety and 
depression screening (Zigmond and Snaith, 1983). It has been subjected to extensive 
validation (Herrmann, 1997). It is composed of 14 items, seven of which are related to 
anxiety and seven to depression, with each item having four possible responses scored 
0, 1, 2 or 3. The scale used I a Likert scale and the two subscales of anxiety and 
depression have been found to be independent measures. Scores on each subscale of 
less than, or equal to 7, are considered normal (Snaith and Zigmond, 1986).  
 
2.4.6 Assessment of motion sickness susceptibility 
The subjects were assessed for motion sickness susceptibility when screened using a 
validated motion sickness susceptibility questionnaire, MSSQ (Golding, 1998). The 
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MSSQ predict subjects' likely reaction to visually induced motion sickness nausea by 
asking for past experiences of nausea in various every-day-life situations. The 
questionnaire was commonly used for the selection of susceptible subjects [e.g., 
(Klosterhalfen et al., 2005a, Klosterhalfen et al., 2005b)]. 
 
2.4.7 Assessment of visual motion induced nausea 
The subjects were assessed for motion sickness sensations immediately before and 
after exposure to the stimulus. Two most commonly used questionnaires to assess 
motion sickness are the Simulator Sickness Questionnaire (SSQ) and the Motion 
Sickness Assessment Questionnaire (MSAQ) The SSQ (Kennedy et al., 1993) was 
validated originally with aircraft simulators but later also with marine vehicle motion 
sickness (26 sensations scoring none, slight, moderate, severe). Meanwhile, the MSAQ 
(Gianaros et al., 2001) was validated using rotating optokinetic drum and developed to 
measure the multiple dimensions of motion sickness with 16 sensations (gastrointestinal 
(predominantly nausea), central, peripheral and sopite-related) on a visual-analogue-
scale (VAS). The MSAQ correlated strongly with other commonly used nausea 
questionnaires (Pensacola Motion Sickness Questionnaire Diagnostic Index, r=0.81, 
p<0.01 (KELLOGG et al., 1965); and the Nausea Profile, r = 0.92, p<0.01 (Muth et al., 
1996). The MSAQ records the subject’s experience of each of 16 descriptors on a 
visual-analogue-scale of 1 (not at all) to 4 (severe). To score the MSAQ: (1) sum the 
points scored for GI distress questions (e.g., nausea); (2) sum the points scored for 
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central distress questions; (3) sum the points scored for peripheral distress questions;  
(4) sum the points scored for sopite syndrome questions; and (5) sum the total points 
scored.  
A validated nausea VAS questionnaire (Bijveld et al., 2008b) was also used every 
minute during each video and a detailed MSAQ used just before and after each video 
documented any sensations reported by the subjects. The VAS was validated with a 
similar virtual reality video stimulus and correlated with real physical rotations. A scale 
from 1 to 4 with 1 being, without sensation, and 4 being maximum level of tolerated 
sensation (e.g., severe nausea) was used. The peak nausea minute-to-minute scores 
(majority at the last minute of the video) were used for comparisons. 
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2.5 Preparation for experiment 
Subjects were comfortably seated in a silent room maintained at a temperature of 25oC 
and the following electrodes, cuffs and belt attached as indicated below (Figure 5): 
 
Figure 5. A subject with electrodes attached as described (reproduced with subject’s 
consent). 
 
1. Three ECG electrodes to the skin of the left and right infraclavicular areas and 
the cardiac apex. 
2. A photoplethysmographic-cuff (Finapress®, Ohmeda) attached to the middle 
phalanx of the right middle finger, to measure the systolic, diastolic, and mean 
blood pressure for each and every heart beat.  
3. A piezoelectric plethysmographic belt placed around the chest at the level of the 
xiphisternum to measure breathing movements. 
…… 2 
1 
4 
3 
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4. Two dry, bright-plated, bipolar electrodes with Velcro straps were attached to the 
middle phalanx of the ring and index fingers of the left hand to measure skin 
conductance response. 
 
2.6 Baseline activity 
Subjects were encouraged to relax their muscles, stay still and not talk while baseline 
recordings were taken over 10 minutes before the start of the stimulus after the subjects 
have had time to relax for up to 30 minutes before. 
 
2.7 Exposure to stimulus 
Subjects watched two different videos consecutively through a black card board 
designed to limit their field of view to only the screen. The videos consisted of; 
§ a non-nausea inducing video consisting of a stationary cityscape (control or neutral 
video) and 
§ a nausea inducing video consisting of a moving cityscape (nausea video)  
The sequence of exposure was assigned randomly by the investigator. All events, 
including reported sensations were recorded on a data collection sheet. 
 
The first and second videos were separated by a washout period of 20 minutes during 
which subjects continued to be questioned every minute for sensations of nausea, 
anxiety or dizziness until no sensations are reported. This was to avoid a carry-over 
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effect of sensations from one video onto another and allow EGG recording for the 
exposure period to be complete.  
 
A video of the cityscape rotating as seen from the perspective of a subject standing on 
Westminster Bridge, London, UK was used. The video was composed of a sequence of 
digital camera images of the bridge taken from the viewpoint of a subject standing on 
the bridge. The images were processed on a PC using programs by 3DSTATE to 
provide a video sequence with a frame resolution of 1024 by 768 pixels at 16-bit color 
which was projected with an Acer H5360Eco projector at a refresh rate of 60 Hz onto a 
screen of 2.00 m x 2.00 m placed at a distance of 1.12m from the subject (validated by 
(Bijveld et al., 2008b). The control video showed a static scene of the above. The lights 
were turned down and the subject watched the video for 10 minutes or until severe 
nausea (rating of 4) occurs, whichever happens first. A red target was put in the video at 
regular intervals to assess the subject’s attention on the video. 
 
2.8 Nausea markers 
During the videos, subjects were questioned every minute about sensations of nausea, 
anxiety and any related complaints which they rated on a visual-analogue-scale of 1 
(not at all) to 4 (severe). Just before and just after the video subjects also completed the 
STAI-state anxiety assessment and the MSAQ to assess motion sickness sensations 
including nausea. Vital signs and skin conductance responses were recorded 
continuously throughout the experiment. As the autonomic activity is a dynamic one, the 
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means for the last third of the video is used for comparisons as that is when subjects 
report their peak nausea levels and the peak associated autonomic changes are 
expected (Figure 14, Figure 15, Figure 16, Figure 17, Figure 18). 
 
2.9 The autonomic nervous system 
Autonomic nervous system (ANS) function can be directly measured with needle 
recordings of the peroneal nerve, and direct stimulation of vagal nerves via implantable 
vagal stimulators. However they are invasive and impractical for human experimental 
studies. Following that, indirect measures of cardiac autonomic function have been 
developed with the most popular being heart rate variability (HRV).  
HRV was first appreciated clinically in 1965 when Lee and Hon  demonstrated that 
alterations in the inter-beat intervals between successive R waves in the ECG preceded 
foetal distress before any appreciable changes occurred in the heart rate itself (Lee and 
Hon, 1965). These oscillations in the interval between successive heart beats or “HRV” 
has been used in preference to crude heart rate in the majority of the more recent 
autonomic research. 
 
2.9.1 Beat-to-beat measures 
Beat-to-beat measures, irrespective of time frame or assumptions of respiratory 
stationarity, represent direct measures of autonomic tone. The examples include CVT 
and cardiac sensitivity to the baroreflex (CSB). 
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2.9.2 Cardiac vagal tone 
Cardiac vagal tone (CVT) is a measure of cardiac parasympathetic efferents via the 
vagus nerve. BP increases momentarily in ventricular systole causing baroreceptor 
activation in the carotid sinus and pulmonary circulation, which increases their rate of 
discharge (McAllen and Spyer, 1978). A vago-vagal reflex is then initiated via medullary 
neurones in the NTS, by stimulating preganglionic neurones of the vagal nerve to 
increase firing. The increase in cardiac vagal activity reduces the rate of spontaneous 
depolarisation of the sino-atrial node, widening the RR interval and decreasing heart 
rate. The humans vagal response to baroreceptor stimulation is around 240ms that is 
fast enough to delay the subsequent systole (Eckberg, 1976). Notwithstanding the 
sympathetic influence on heart rate, mainly through changes in peripheral vascular 
resistance which takes place more slowly, vagal tone can be calculated non-invasively 
by measuring beat-to-beat changes in RR intervals. 
Based on these principles, the NeuroscopeTM (MediFit Instruments, Essex, UK) 
analyses the RR interval from a standard 3 lead ECG (5kHz sampling) to derive the 
CVT, a real time index of parasympathetic activity is recorded. The acquired QRS 
complexes are compared to a QRS template generated from the initial recordings. A 
1mV pulse is generated by voltage oscillators if there is sufficient similarity between the 
recorded complex and template with the time between 1mV pulses equivalent to the RR 
interval on the ECG. This pattern of 1mV pulses is sent to two circuit limbs known as the 
high pass limb and the low pass limb. The low pass limb produces a damped version of 
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the signal while the high pass limb tracks the incoming signal without transforming it. 
The slower the rate of change of the incoming signal, the lower the rate of HRV will be. 
And the closer the output match is between the high and low pass limbs the lower the 
CVT will be as well. In reverse, a higher CVT reading is the result of a higher the HRV 
(the faster the rate of change of the incoming signal) causing more dampening of the 
low pass circuit output in comparison to the high pass limb (see Figure 6). 
 
Figure 6 The beat-to-beat measure of cardiac vagal tone as measured by the 
Neuroscope, using voltage oscillators with high (non-damped) and low (damped) circuit 
limbs. This diagram is reproduced with permission from Farmer, 2010. 
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This methodology has been validated in humans and animals and the CVT is measured 
on an experimentally derived linear vagal scale (LVS) (Julu, 1992). The zero point on 
the LVS was derived from six fully atropinised healthy volunteers, and 10 units on the 
LVS established in the same fasting volunteers in the supine position (i.e. maximal 
vagal activity) (Janig and Kollmann, 1984). Thus, CVT may be considered a validated 
marker of parasympathetic tone outflow from the brainstem to the heart. 
 
2.9.3 Cardiac sensitivity to the baroreflex 
Cardiac sensitivity to the baroreflex (CSB) a validated, non-invasive beat-to-beat 
measure of parasympathetic afferent activity is measured with a non-invasive 
continuous blood pressure measurement using the Portapress system (Finapress, 
Amsterdam, Netherlands). The Neuroscope uses the raw Nexfin waveform to calculate 
the arithmetic mean of the blood pressure (BP), as opposed to the mean arterial blood 
pressure (MAP) that is commonly used in clinical settings (MAP = DBP + 1/3(SBP – 
DBP). The mean blood pressure (MBP) calculated by the Neuroscope is the true 
arithmetic mean of the BP, i.e. diastolic blood pressure (DBP), dicrotic notch and the 
systolic blood pressure (SBP). CSB is expressed as a ratio of 'mmHg/'RR interval and 
calculated as the change in pulse interval per unit change in SBP over a 10-second 
period by integrating the RR interval data with the BP data (see Figure 7). 
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Figure 7 CSB is a beat-to-beat measure of parasympathetic afferent tone derived from 
changes in BP and expressed as a function of change in RR interval. 
 
2.10 Selective Sympathetic Measures  
2.10.1 Vasomotor 
Mean arterial pressure was correlated with invasively recorded sympathetic activity via 
photo-plesythymography (Petersen et al., 1995) that records MBP on a beat-to-beat 
basis and has been validated against invasive arterial pressure measurements in 
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humans (Vetrugno et al., 2003). However, vasoconstriction can ensue if the cuff is 
applied to a subject’s finger for a considerable period of time. Thus selecting the wrong 
finger cuff size can result in large fluctuations in BP readings. The BP cuff was placed 
on the subjects’ left middle finger in this experiment.  
 
2.10.2 Sudomotor  
The sudomotor, or skin conductance response (SCR), used for more than 100 years, is 
a measure of central sympathetic control over sweat gland activity. It is defined as, 
“...momentary change of the electrical potential of the skin, (it) may be spontaneous or 
reflexively evoked by a variety of internal or by externally applied arousal stimuli 
(LOMBARDI and MALLIANI, 1996).” SCR assesses sympathetic cholinergic sudomotor 
function, and represents a transient change in the electrical resistance of the skin 
associated with sweating elicited by an arousal or orienting stimulus. Animal studies 
show efferent sweat fibres originating in the hypothalamic preoptic sweat centre, 
descend through the ipsilateral brainstem and medulla to synapse with the 
intermediolateral cell column neurons. The unmyelinated postganglionic sympathetic 
class-C fibers arise from sympathetic ganglia joining the major peripheral nerves and 
reaching the sweat glands (LOMBARDI and MALLIANI, 1996). Two interacting types of 
sweat response are thermal and emotional. Emotional or mental sweating control 
involves multiple interactions with emotional, cognitive and neuroendocrine functions. It 
is controlled at multiple levels within the central nervous system, mainly at the anterior 
cingulate cortex. 
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One method is to measure spontaneous impedance changes across digits (galvanic 
skin responses or “GSR”). Another is to pass a small, constant current across the digit 
and record impedance changes as it crosses the digit (SCR) – with the latter felt to be 
more reliable. The Powerlab (AdInstruments, UK) biosignals acquisition system can 
record SCR, which were recorded at baseline and after the videos. The SCR electrodes 
were placed on the subjects’ left index and ring finger.  
 
2.11 Statistical analysis  
Psychometric, autonomic cardiac and gastric data and cortisol data had matched-pair t-
tests and Wilcoson tests used to compare the means and medians. Pearson’s and 
Spearman’s correlations were used to determine the relationship between 
measurements. The ANS axis data was normally distributed. Continuous variables are 
expressed as mean ± standard error of mean. Independent-measures t-tests and Mann-
Whitney tests were used to compare groups. Multi-group comparisons used a one-way 
ANOVA with Bonferroni correction. Commercially available statistics packages (SPSS, 
Chicago, IL, USA and GraphPad, San Diego, CA, USA) were used for the analysis. P 
values <0.05 were considered to be of statistical significance. 
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3. Results 
Twenty healthy volunteers were recruited from among the staff and students of QMUL. 
All underwent and completed the experiments. No vomiting or unexpected adverse 
events were recorded. 
 
3.1 Subject characteristics 
Ten males and 10 females with age range of 20 - 40 years (mean 27.65 ± 6.98) were 
studied with the mean BFI personality subclass scores of the subjects shown in Table 1. 
 
Personality subclass Mean score ± SEM (%) 
Openness 70.38 ± 2.79 
Conscientiousness 61.81 ± 3.11 
Extroversion 52.97 ± 3.41 
Agreeableness 74.13 ± 2.44 
Neuroticism 43.93 ± 3.96 
Table 1. BFI personality subclass mean scores of subjects   
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Females and males did not have any statistically significant differences as shown in 
Figure 8. 
 
Figure 8. Sex distribution of BFI personality subclass of subjects. 
 
The mean STAI trait anxiety score was 38.7 ± 2.01. The females (44.8) scored higher 
than males (35.6), but it was not statistically significant. The motion sickness 
susceptibility questionnaire mean percentage of motion sickness susceptibility was 
66.58% ± 29.55 (range 0 - 99).   
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3.2 Effects of videos on subjective sensations 
The GI (mainly nausea) and central (CN) scores were significantly greater after the 
nausea video compared to control with no significant differences in peripheral (PH) and 
sophite related (SR) sensation scores between the two videos (Figure 9). 
 
Figure 9. Motion sickness sensation score for the nausea and neutral videos 
 
Fifteen subjects (8 females) had nausea with mean nausea rating of 2.55 ± 0.32 and 
five (3 females) reported severe nausea that warranted stopping the stimulus with the 
subjects closing their eyes. The distribution of percentage change in nausea scores of 
all subjects after the nausea video is shown in Figure 10. 
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Figure 10.  Percentage change in nausea scores for individual subjects after the nausea 
video with two clusters of susceptible subjects above the midline and resistant subjects 
at 0%. 
 
The mean percentage change in nausea score from just before each video to the 
maximum experienced as rated by the subjects on the MSAQ cumulative GI distress 
scores at the end of each video was significantly higher for the nausea video than for 
the neutral video (+2.11% vs 0.13% p<0.01).  
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Figure 11. Mean nausea levels during and after the nausea and control videos for all 
subjects. Mean nausea levels increased gradually throughout the ten minutes duration 
of the nausea video and reached the peak level at the 10th minute (mean nausea rating 
=1.73±0.02) compared. There was a steep decrease in mean nausea levels during the 
five minutes post-video recovery period. Mean nausea levels during the control video 
remained near baseline values during and after the video. There was a significant 
difference in mean nausea levels between the nausea and control videos (p<0.01). 
(Ratings - 1=nil; 2=mild nausea; 3=moderate nausea; 4=severe nausea) 
 
As shown in Figure 11, nausea levels increase significantly during the nausea video, 
peaking at the 10th minute, when compared to the control video. Upon cessation of the 
nausea video, nausea levels diminished to near-baseline values within 5 minutes. 
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Nausea levels during the control video remained close to baseline values throughout 
and after the video. 
Mean state anxiety score was higher before the neutral video than before the nausea 
video, however the change in score was greater during the nausea video (4.7) than 
during the neutral video (-0.05) (p=0.015). At the end of the videos, the score was 
greater for the nausea video than for the neutral video, Figure 12. 
 
Figure 12. Anxiety scores before and after watching the videos. 
 
Motion sickness sensations resolved in all subjects at the end of the videos. Resolution 
of nausea occurred in an average of 3.85 minutes (range 0 – 18) and other sensations 
in 3.75 minutes (range 0 – 14) 
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3.3 Effects of videos on ANS biomarkers 
Levels of ANS biomarkers did not differ significantly between baseline, just before the 
neutral video and just before the nausea video (p> 0.05). All subjects showed changes 
in their autonomic biomarkers during the videos. Whereas the mean percentage change 
in HR, MBP and CSI increased significantly more during the nausea video than during 
the neutral video, CVT and CSB declined, although the CVT fall was not statistically 
significant, see Figure 13. 
 
Figure 13. Mean percentage change in ANS biomarkers during neutral and nausea 
videos.  
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Also, the differences in the effects of the neutral and nausea videos on the autonomic 
biomarkers was greatest in the late phase of exposure to the videos, i.e. in the period 
leading to maximum sensations necessitating premature termination of the video or the 
full 10 minutes of the video as shown Figure 14 to Figure 18.  
 
Figure 14. Phasic changes in mean HR during exposure to neutral and nausea videos.  
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Figure 15. Phasic changes in MBP during the exposure to the neutral and nausea 
videos  
 
Figure 16. Phasic changes in mean CSI during exposure neutral and nausea videos 
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Figure 17. Phasic changes in mean CSB during exposure to neutral and nausea videos 
 
 
Figure 18. Phasic changes in mean CVT during exposure to neutral and nausea videos. 
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Skin conductance response (SCR): All subjects experienced changes in their SCR 
during the videos. However, there was no significant difference in the mean SCR 
changes during the nausea video and the neutral video, (-5.074 vs -5.462. p= 0.764). 
Also, there was no significant correlation between the mean nausea score and the 
mean ANS biomarker levels of the subjects as shown in Table 2. 
 
ANS biomarker Pearson’s correlation, r. p-value 
HR (bpm) -0.139 0.570 
MBP (mmHg) 0.094 0.700 
CSI 0.000 0.998 
CVT (LVS) 0.202 0.407 
CSB (∆RR/∆mmHg) O.257 0.288 
Table 2. Correlation between mean nausea score and the ANS biomarker levels. 
 
3.4 Differences between nausea susceptible and resistant 
subjects 
The 5 subjects who did not experience any nausea and the other 5 who experienced 
severe nausea were grouped as ‘nausea resistant’ (NR) and ‘nausea susceptible’ (NS) 
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respectively for these comparisons. There was no significant difference between the 
mean percentage visually induced motion sickness nausea susceptibility, assessed by 
MSSQ, of the NS (68.75%) and NR subjects (65.82%) (p= 0.864). 
 
Mean personality subclass scores also did not differ significantly between nausea 
susceptible and resistant subjects (Figure 19).  
 
Figure 19. Personality subclass mean scores of nausea susceptible and nausea 
resistant subjects    
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There was also no significant difference between mean trait anxiety score for NS and 
NR subjects. However, state anxiety increased to a significantly higher score for NS 
subjects at the end of the nausea video (Figure 20).  
 
Figure 20. Trait anxiety scores and changes in state anxiety for nausea susceptible 
(NS) and nausea resistant (NR) subjects after watching the nausea video.  
 
The mean score for maximum GI (mainly nausea), CNS and sopite related sensations 
experienced as rated by subjects at the end of each video was significantly greater for 
the NS subjects than the NR group. The difference in peripheral sensation score was 
however not statistically significant as shown in Table 3. 
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Motion sickness category NR NS p-value 
GI (nausea) 5.00 35.60 <0.01 
CNS 6.40 31.60 <0.01 
SOPITE-RELATED 7.40 17.00 <0.03 
PERIHERAL 3.00 11.80 0.074 
Table 3. Mean scores of the different motion sickness sensation categories for nausea 
resistant and nausea susceptible subjects.   
 
There were no differences in the baseline autonomic marker levels of the NS and NR 
groups (Table 4). During the nausea video these markers including SCR showed 
greater change in the nausea susceptible than nausea resistant subjects, the difference 
was not statistically significant (Figure 21). 
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ANS  BIOMARKER NR NS p-value 
HR (bpm) 65.55 ± 2.12 62.04±2.05 0.58 
MBP (mmHg) 78.65±3.56 81.96±4.02 0.51 
CSI 2.37±0.17 2.47±0.25 0.86 
CVT (LVS) 12.97±1.10 13.62±1.02 0.88 
CSB (∆RR/∆mmHg) 11.98±1.55 12.98±1.26 0.82 
Table 4. Mean baseline ANS biomarker values for nausea resistant and nausea 
susceptible subjects. 
 
 
Figure 21. Mean percentage change in ANS biomarker values of nausea susceptible 
(NS) and nausea resistant (NR) subjects. 
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4 Discussion 
This was a pilot study to validate the motion and control video and the results herein 
discussed must be viewed with this in mind. 
 
4.1 Visual motion induced nausea 
Visual motion induced nausea is the result of sensory conflict in inputs from the visual 
versus vestibular systems (Lackner and Dizio, 2006) and leads to gastrointestinal (e.g. 
nausea) and central sensations in healthy volunteers in this study. Nausea in 75% of 
the subjects compares favourably with 50% reported for a rotating optokinetic drum 
(Kiernan et al., 1997). The safety profile that is crucial for the adaptation of a nausea 
stimulus to fMRI studies was met with no volunteers retching or vomiting for all visits.  
 
4.2 Nausea associated psychophysiological measures 
There was significantly increased state anxiety after watching the motion video 
consistent with the unpleasant nature of nausea causing much anxiety and discomfort 
with increased anxiety states and anticipation reportedly leading to more severe nausea 
responses (Morrow et al., 2002b). 
There were also significant increases in heart rate, mean blood pressure and cardiac 
sensitivity index consistent with the classical increased sympathetic activation in vection 
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experiments (Cowings et al., 1986, Himi et al., 2004).  Skin conductance response, the 
other marker of sympathetic activity, did not show similar changes and possibly may 
indicate poorer findings with finger measurements compared to metopic or forehead 
skin conductance response (Golding, 1992). 
Contrary to previous reports (Cowings et al., 1986, Himi et al., 2004), the CSB 
withdrawal was significant with CVT lower but not significantly during the nausea video. 
When divided into 3 phases; early, mid and late significant decreases in both 
components of are noted in the late phase of video exposure which follows the maximal 
nausea ratings at the late third of the video and this was used for the rest of the 
experiments. Both SNS and PNS markers were not correlated with nausea severity and 
probably due to the small sample size. Interestingly, a study of the ANS response to a 
similarly subjective and distressing sensation, pain, rather showed co-activation of PNS 
and SNS, a phenomenon referred to as ‘tonic freeze’ (Paine et al., 2009). The reasons 
for this complexity in ANS response requires further exploration. 
 
4.3 Limitations and the way forward 
It is encouraging that with such small numbers we were able to show significant 
differences with nausea induction as well as its associated psychophysiological 
measures. However a much larger study is needed to assess if these results still hold 
true for a larger population with a separate reproducibility study performed to assess 
 84 
 
reliability of the repeat study. Furthermore, the study of the psychological factors was 
largely under powered as such studies usually require large sample size.  
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1 Introduction 
1.1 Individual variability to motion sickness nausea 
There are considerable individual differences in the development of motion induced 
nausea (Golding, 2006). According to transport surveys, the individual susceptibility to 
motion sickness appears to change with age. It starts sometime during childhood, peaks 
at around puberty and slightly declines through adulthood (Turner and Griffin, 1999).  
Females also appear to be more susceptible to nausea and vomiting (Quigley et al., 
2001, Klosterhalfen et al., 2005a, Flanagan et al., 2005) with ferry passengers having a 
5 to 3 female to male risk ratio for vomiting (Lawther and Griffin, 1988). This may be 
partly due to the effect of female hormones (Golding and Gresty, 2005) as some 
changes in susceptibility motion induced nausea are noted with the menstrual cycle 
(Matchock et al., 2008) and also during pregnancy (Walsh et al., 1996).  
 
It is suggested that about half of motion sickness susceptibility is determined by genetic 
variation and that the improvement in adulthood is because of individual differences in 
habituation, exposure to and avoidance of motion (Reavley et al., 2006). A large scale 
survey of female twins found greater sensitivity to motion induced nausea in 
monozygotic twins (0.56, n=702) in comparison with dizygotic twins (0.16, n=727) and 
susceptibility decreased with age in both groups. This supports the age-old clinical 
anecdote that motion sickness ‘runs in families’. There also appears to be slightly higher 
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susceptibility to motion sickness amongst people of Chinese origin (Stern et al., 1993, 
Klosterhalfen et al., 2005a). 
 
Psychological factors can also influence nausea susceptibility (Morrow et al., 2002b). 
Haug et al. (2002) demonstrated that anxiety and depression are associated with 
nausea susceptibility. Patient expectation of nausea during treatment has also been 
shown to increase the severity of nausea (Roscoe et al., 2000).  
 
Smokers are also more susceptible to motion sickness when at their normal level of 
cigarette use than when they are nicotine deprived (Golding et al., 2011). Greater 
aerobic fitness also reportedly makes an individual more susceptible to motion sickness 
(Rawat et al., 2002). 
 
Acute vestibular disorder cause intense vertigo, nausea, and imbalance. In chronic 
vestibular disorders patients can become susceptible to vection and visually induced 
imbalance as they become over-reliant on visual cues for orientation (Pavlou et al., 
2004, Guerraz et al., 2001). Spatial disorientation appears to play a role in these 
patients and in those suffering from visual vertigo; this is evident from the abnormally 
strong nausea that develops to disorienting visual environments (Guerraz et al., 2001). 
 
Physiological factors that worsen motion sickness usually involve a ‘conflict’ between 
sensory inputs (Rainford et al., 2006). A classic example is reading in a moving vehicle 
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where the vestibular ocular reflexes (stabilizes eyes on external stationary objects) must 
be suppressed by visually guided eye movements to maintain scanning fixation on the 
text which is moving with the protagonist. Similar ‘conflicts’ arise in ‘tilting trains’ or an 
airplane making coordinated turns when landing or taking off which are particularly 
nauseogenic if the passenger feeling completely upright inside views the external 
landscape that appears to swing dramatically up and down (Neimer et al., 2001). 
 
Last but not least, these various traits may not be independent e.g. patients undergoing 
chemotherapy treatment who are susceptible to visual motion induced nausea have 
more post-chemotherapy nausea than patients who aren’t susceptible (Morrow, 1985).  
 
Possible Factors Possible Causes of Increased Susceptibility to Nausea 
Physiology High aerobic fitness 
Lifestyle Past experience of motion-induced nausea, alcohol abuse, smoking cigarettes 
Psychology Spatial disorientation, depression, anxiety, expectation, anticipation, fear 
Neuroendocrinology Cortisol, vasopressin 
Genetics Oriental ethnic origin, α2-adrenergic receptor genes single nucleotide polymorphism, familial history 
Gender Female 
Disease Migraine, vestibulopathy 
Age Young children, peaking at puberty 
 
Table 5. Factors possibly contributing to nausea susceptibility in healthy individuals. 
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1.2 Psychophysiological markers of nausea 
The autonomic nervous system (e.g. cardiac autonomic systems, stomach autonomic 
activity and skin conductance responses), neuro-endocrinal systems and psychological 
state like anxiety are currently known markers associated with nausea. 
 
Anxiety is part of the generalised response to a aversive stimulus like nausea and plays 
an important role in the susceptibility to nausea and and its severity (Haug et al., 2002). 
A standardised method of assessing anxiety is the Spielberger state and trait anxiety 
inventory (STAI; chapter 2 section 2.4.3). 
 
The autonomic nervous system (ANS) appears to have an important role in nausea with 
generally sympathetic activation and parasympathetic withdrawal occurring during 
nausea (Cowings et al., 1986, Himi et al., 2004, Hu et al., 1991). Furthermore, the ANS 
may also have a role in predicting nausea susceptibility (Muth, 2006) with high resting 
sympathetic tone (Parker and Wilsoncroft, 1978a), low resting parasympathetic tone 
(Rawat et al., 2002), and parasympathetic activation in response to nausea  
(Uijtdehaage et al., 1992) being protective against nausea. 
 
Monitoring the electrical activity of the gut via electrogastrography (EGG) shows the 
final outcome of autonomic nervous system influence on the GIT during nausea.  
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1.3 Electrogastrography 
Electrogastrography (EGG) measures gastric myoelectrical activity (GMA) that 
regulates gastric motility (Chang, 2005) with slow waves from interstitial cells of cajal 
(gastric pacesetter potentials) modulating maximum frequency of spike potentials that 
initiate gastric muscles contraction (Koch, 2001). The frequency presumed to be of 
gastric origin and at which the power in EGG power spectrum peaks in the range of 
0.5–9.0 cycles per minute (cpm) is the EGG dominant frequency while the dominant 
power is the power during that dominant frequency. Simultaneous mucosal (Stern, 
2000, Stevens LK, 1974) or cutaneous and serosal (Tumpeer and PHILLIPS, 1932a, 
Brown et al., 1975, Smallwood, 1978, Linkens and Datardina, 1978) recordings of GMA 
have shown that the dominant frequency of the EGG accurately represents the gastric 
slow wave frequency. The amplitude and regularity of gastric slow waves reflects the 
dominant power.  
 
There is no established definition for the normal range of the gastric slow wave but 
generally the normal dominant frequency of the EGG in asymptomatic healthy subjects 
is accepted to be between 2.0 and 4.0 cpm (Chen et al., 1994, Chen and McCallum, 
1992, Chen et al., 1993a, Parkman et al., 2003). The abnormal frequencies may be 
divided further into tachygastria if its frequency is >4.0 cpm, but <9.0 cpm, bradygastria 
if its frequency is <2.0 cpm and arrhythmia if there is a lack of a dominant frequency 
(Chen et al., 1995). This can be quantitatively assessed further to determine the 
percentage of time during which normal slow waves (% EGG in normogastria) are 
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observed in the EGG. In contrast to normogastria, the percentage of gastric 
dysrhythmia is defined as the percentage of time abnormal gastric rhythm (includes 
tachygastrias, arrhythmias and bradygastrias) is observed in the EGG (% EGG in 
dysrhythmias). 
 
Dr. Stern wrote in 2000, ‘‘the history of EGG can be described as three beginnings, a 
length period of incubation, and a recent explosion’’ (Stern, 2000). Historically, the first 
human electrogastrography was first performed by a gastroenterologist Walter Alvarez 
back in the early 1920s (Alvarez, 1922, Stern, 2000), by placing two electrodes on the 
abdominal surface of ‘‘a little old woman’’ connected to a galvanometer. Meanwhile I. 
Harrison Tumpeer, a pediatrician performed the first EGG in children (Tumpeer IH, 
1926, Tumpeer and PHILLIPS, 1932b)(Tumpeer IH, 1926) with limb leads to record the 
EGG from a 5 week old child suffering from pyloric stenosis. Thirty years later EGG was 
recovered by R.C. Davis, a psychophysiologist, with validation of the EGG using 
simultaneous recordings from needle electrodes and a swallowed balloon (DAVIS et al., 
1957, DAVIS et al., 1959). This stimulated EGG research, with Dr. Stern working in 
Davis’ lab in 1960 (Stern, 2000) and Stevens and Worrall who were probably the first 
ones applying spectral analysis to EGG (Stevens LK, 1974). England also joined with 
studies on frequency analysis of the EGG signal e.g. fast Fourier transform (FFT) 
(Brown et al., 1975), phase-lock filtering (Smallwood, 1978), and autoregressive 
modeling (Linkens and Datardina, 1978). They also reconfirmed there was no 1:1 
correlation between the EGG and the contractions (Nelsen and Kohatsu, 1968) so the 
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frequency of the contractions can be determined but not when they were occurring 
(Chen and McCallum, 1991). Running spectral analysis method using FFT was 
introduced (van der Schee and Grashuis, 1987) to extract the frequency of EGG and 
time variations of the frequency (Stern et al., 1987b, Pfister et al., 1988, Stern et al., 
1987a) that is still used today (Chen JZ, 1994). Chen (Chen, 1989, Chen et al., 1990) 
improved it with an adaptive autoregressive moving average model (avoiding averaging 
effect by FFT block processing) to detect gastric dysrhythmia in short durations (Chen 
et al., 1993b). 
 
The EGG during optokinetic drum rotation period showed a decrease in normogastria, 
which was accompanied with an increase in tachygastria with increasing reports of 
nausea (Imai et al., 2006). GMA also shows a dominant frequency of 3 cpm (cycles per 
minute) during fasting periods with an increase in frequency during nausea (Stern et al., 
1985) (Holmes and Griffin, 2000) and (Miller and Muth, 2004). The same was seen 
between subjects susceptible to motion sickness versus subjects resistant to motion 
sickness (Muth et al., 1995).  
 
Muth (2006) argued that in trying to piece all of these markers of nausea together the 
variations in susceptibility seen are unaccounted for by autonomic nervous system 
changes alone and may likely be accounted for by the gastric and neuroendocrinal 
system changes. 
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1.4 Neuroendocrinal System influence on nausea 
The HPA axis is central in orchestrating the body’s response to stress. Cortisol, a 
glucocorticoid hormone, is the final effector of this axis and can be assayed in biological 
fluids including peripheral blood, saliva and urine (Figure 22). Approximately 3-5% of 
cortisol is in its bioactive, unbound form with the majority of cortisol bound to the 
corticosteroid binding globulin or albumin while in the blood, preventing it from 
penetrating the membrane of the target cell.  
 
Acutely occurring nausea and vomiting releases “stress hormones” (Drummond, 2005, 
Kohl, 1992, Klosterhalfen et al., 2000) and thus raise the question of whether the 
development of motion sickness or nausea in general involves the neuroendocrinal 
systems. Nausea is correlated with an increase in serum cortisol (Eversmann et al., 
1978) and vasopressin levels, likely a response to a stressful nauseous event (Otto et 
al., 2006, Grigoriev et al., 1988). Although how cortisol is synthesised and released into 
the blood is known (Kohl, 1985, Kohl, 1992), however, it is still unclear whether the 
cortisol release is the direct result or cause of nausea in humans (Otto et al., 2006).  
 
Stress hormone profiles of cortisol and vasopressin during nausea currently appear to 
be the result of nausea rather than the cause, however further investigations during 
different experimental nausea stimulations and using newer neuroendocrinal system 
markers might clarify whether gastrointestinal peptides acting as neurotransmitters and 
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stress hormones play a specific role in the development of acute nausea and vomiting 
(Otto et al., 2006). 
 
Figure 22 The hypothalamic-pituitary-adrenal axis. Corticotropin-releasing hormone is 
secreted from the hypothalamus following a stressful stimulus, which then stimulates 
the anterior pituitary to release adrenocorticoptropic hormone (ACTH). ACTH is carried 
via the blood stream to the adrenal glands and stimulates the production of cortisol. 
(adapted from www.ahs.uwaterloo.ca, retrieved 8th August 2012) 
 
1.5 Identifying Suitable Study Subjects 
Subjects need to be screened before they are selected for fMRI studies as there are 
wide individual variations to visual motion induced nausea. This is related to individual 
differences in susceptibility that will be explored in more detail later. With regards to 
selecting suitable individuals for fMRI studies, only those with at least moderate to 
severe nausea compared with those who don’t experience nausea have the best 
chance of discovering the differences between nausea susceptible (NS) and nausea 
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resistant (NR) individuals. On top of that, self-reported nausea should be validated with 
associated psychophysiological measures to ascertain when an individual reports 
increased visual motion induced nausea levels there is a corresponding change in the 
psychophysiological markers as well.  
 
1.6 Knowledge gaps  
The understanding of the neuropsychophysiology of nausea is imperative for the 
development of effective treatment against nausea. However, the comprehensive 
understanding of the mechanisms of nausea is still lacking. The lack of validated 
models of nausea as well as objective biomarkers of nausea has significantly hampered 
the research of this complex sensation (Holmes et al., 2009). Furthermore, nausea 
research can be advanced further using a novel objective human nausea model whilst 
reducing the need for unnecessary animal studies.  
 
1.7 Aims 
The aims of this study were to identify individuals who are susceptible and resistant to 
develop nausea without vomiting using a human model of visual motion and to identify 
the psychophysiological markers for nausea. 
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1.8 Hypothesis 
By using the human model of visual motion we can induce nausea in a significant 
proportion of the study population which can be objectively measured by observing 
changes in the autonomic nervous system, neuroendocrinal system, EGG and fMRI. 
This will help the identification of nausea susceptible and resistant individuals . 
 
2 Methods 
2.1 Study design and setting 
This was a randomised crossover study carried out at the Wingate Institute of 
Neurogastroenterology, Queen Mary University of London (QMUL). 
 
2.2 Ethical approval 
The QMUL Research Ethics Committee (QMREC2008/37) approved these studies. 
	  
2.3 Subjects 
Ninety-eight healthy volunteers completed the studies. All subjects signed  written 
informed consent. Volunteers were recruited to meet the following criteria: (i) normal 
body mass index, (ii) no abnormality on clinical examination, including a history or 
presence of cardiac, ophthalmologic, gastro-intestinal, hepatic, or renal disease, or 
other condition known to alter their response to visually induced motion sickness 
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nausea e.g. vestibular disease, (iii) no abnormality on electrocardiogram examination at 
screening (iv) no abuse of alcohol (defined as an average intake >21 units per week or 
3 units per day); and (v) no history or presence of neurological or psychiatric conditions 
(e.g. stroke, traumatic brain injury, epilepsy, space-occupying lesions, multiple sclerosis, 
Parkinson’s disease, vascular dementia, transient ischaemic attack, schizophrenia, 
major depression, etc). Subjects with any of the following were excluded: (i) received 
prescribed medication within 14 days prior to the first visit, which might interfere with the 
study procedures or compromise safety, (ii) received over-the-counter medicine within 
48h of the study, (iii) participated in a trial with any drug within 3 months before the first 
visit, (iv) had a caffeinated drink within 24 h of visit. 
 
2.4 Psychometrics and motion sickness susceptibility 
questionnaires 
Validated questionnaires were used to assess different aspects of the psychological 
state and susceptibility to motion sickness of the subjects. The big five inventory (BFI; 
chapter 2 section 2.4.2), the Spielberger state and trait anxiety inventory (STAI; chapter 
2 section 2.4.3), the Weinberger adjustment inventory (WAI; chapter 2 section 2.4.4), 
hospital anxiety depression scale (HADS; chapter 2 section 2.4.5), motion sickness 
susceptibility questionnaire (MSSQ; chapter 2 section 2.4.6), motion sickness 
assessment questionnaire (MSAQ; chapter 2 section 2.4.7) and the validated nausea 
VAS questionnaire (chapter 2 section 2.4.7) were used as previously described.  
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2.5 Preparation for experiment 
After fasting for 6 hours and refraining from drugs, caffeine, alcohol and smoking a day 
before, subjects were studied between 0800 to 1400 hours (both visits performed at 
approximately the same time for each individual). They were prepared as described in 
the previous chapter with the addition of electrogastrography and intravenous access 
for blood sampling. Subjects were seated comfortably in a silent room at 25oC ambient 
temperature and administered questionnaires that assessed motion sickness 
sensations and anxiety. After starting motion or control video, minute-to-minute nausea 
and anxiety scores were monitored using a visual analogue scale. Blood was collected 
for cortisol at baseline and post video 5, 15, 30 minutes. (Figure 23 and Figure 24) 
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Figure 23 Schematic summary of chapter 3 experimental protocol: After 6 hours of 
fasting subjects answered MSAQ & STAI-S questionnaires, reassessed just before 
starting each video during which minute-to-minute nausea and anxiety scores were 
assessed using a VAS were recorded. There were continuous monitoring of cardiac 
autonomic activity and gastric myo-electrical activity throughout. Bloods were also taken 
for cortisol at baseline and post video 5, 15, 30 minutes.  
 
	  
Figure 24 Subject with all the equipment on and investigator observing tracings of EGG, 
EDA and Neuroscope data (reproduced with subject’s consent). 
 100 
 
2.6 Baseline activity 
Subjects were encouraged to relax their muscles, stay still and not talk while baseline 
recordings were taken over 10 minutes before the start of the stimulus. Prior to this the 
subjects had time to relax for up to 30 minutes. 
 
2.7 Exposure to stimulus  
Subjects watched two different videos at two different visits through a black card board 
designed to limit their field of view to only the screen. The videos consisted of; 
§ a non-nausea inducing video consisting of a stationary cityscape (control or neutral 
video) and 
§ a nausea inducing video consisting of a moving cityscape (nausea video)  
The sequence of exposure was assigned randomly by the investigator. All events, 
including reported sensations were recorded on a data collection sheet. 
 
2.8 Nausea markers  
Subjects were questioned every minute about sensations of nausea, dizziness and 
anxiety which they rated on a visual analogue scale with 1 being no sensation and 4 at 
the other end meaning severe nausea or sensation. They also reported spontaneously 
any other sensations. Just before and just after the video subjects also completed the 
STAI-state anxiety assessment and the MSAQ to assess motion sickness sensations 
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including nausea. Vital signs and skin conductance responses were recorded 
continuously throughout the experiment. 
 
2.9 Gastric myoelectrical monitoring with electrogastrogram 
The Medtronic Polygram NET EGG system (Medtronic A/S, Denmark) was used for 
multichannel recordings, with four electrogastrogram (EGG) signals recorded 
simultaneously. Signals were sampled at ~105 Hz and then down-sampled to 1 Hz as 
part of the acquisition process with a low-pass and high-pass filters of 15 cpm and 0.5 
cpm. Six electrodes (Ambu Blue Sensor P, Denmark) were placed on the subject’s 
abdomen after skin preparation with an abrasive electrode paste (Nuprep, Weaver & 
Co, USA). The EGG system was configured to accept an electrode impedance of less 
than 11 kΩ after skin preparation and this was meticulously checked before the start of 
any recordings as the EGG is vulnerable to motion artifacts due to the nature of 
cutaneous measurement, The six electrodes consisted of four active recording 
electrodes, one reference electrode, and one ground electrode. Electrode 3 was placed 
halfway between the xyphoid process and the umbilicus (the conventional location for 
an EGG electrode (Parkman et al., 1997) while electrode 4 was placed 4 cm right 
horizontal to it. Meanwhile, electrodes 2 and 1 were placed 45º to the upper left of 
electrode 3, with an interval of 4 to 6 cm and the ground electrode was placed on the 
left costal margin horizontal to electrode 3. Lastly, electrode 0 (reference) was placed at 
the cross point of the two lines, one horizontal containing electrode 1 and one vertical 
containing electrode 3 (typically coincides with the xyphoid process). A motion sensor 
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was also attached on the abdomen above electrode 4 to aid the elimination of motion 
artefacts from the recording during off line analysis. EGG recordings were measured 
according to established guidelines (Chen and Lin, 2006). 
 
Figure 25 Positions of the EGG channel (ch1-4), reference (R) and ground (G) 
electrodes.  
 
The subject sits in a reclining chair in a quiet room throughout the study and any 
conversations discouraged and reminded regularly to stay as still as possible to prevent 
motion artifacts (Lee and Hon, 1965, Hublet and Demeurisse, 1992, Eckberg, 2006). 
	  
2.10 Serum Cortisol  
There are elaborate and complex sampling systems (Henley et al., 2009) to measure 
serum cortisol to prevent (unintentional) stress of venepuncture however the use of 
such complex systems in these was impractical. Thus, I inserted an intravenous 
cannula (21G Venflon, Beckton, UK) only once into the left antecubital fossa for all 
subjects at the start of the study for peripheral venous blood sampling. This is to 
standardise any potential effects of added stress and in most cases the patency of the 
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cannula was maintained without any intravenous infusion of 0.9% heparinised saline. 
Saline infusion may dilute serum cortisol giving falsely low measurements. A three-way 
extension set (Extension set, SmartSite®, Cardinal Health) with clamps on each of the 
three lines was used with the cannula to prevent any cross contamination between 
serial samples. Peripheral venous blood was collecting in silica clot-activating SST™ 
Vacutainers (Vacutainer, Beckton Dickinson, UK) and spun down and aliquoted to store 
only acellular plasma for further analysis. A portion of the plasma was also transferred 
to the Blood Services Department, Biochemistry Department at the Royal London 
Hospital for serum total cortisol assay with a competitive chemiluminescent assay 
(Chiron Diagnostic ACS:180 analyser, Bayer Healthcare, NY, USA). This assay was 
performed by the Blood Services Department, Biochemistry Department at the Royal 
London Hospital. 
 
2.11 Reproducibility of the nausea study using intraclass 
correlation comparison (ICC) 
After a minimum period of twelve months after their last visit, 20 subjects were randomly 
recruited to participate in a repeat of the same two initial visits. The same measures 
were taken and analysed in the same manner. Subsequently, the intraclass correlation 
(ICC) model for continuous variables were calculated between the both visits for the 20 
subjects (Green et al., 2012).  
 
 104 
 
2.12 Statistical Analysis of Psychophysiological Responses 
Psychometric, autonomic cardiac and gastric data and cortisol data were analysed 
using matched-pair t-tests and Wilcoson tests to compare the means and medians. 
Pearson’s and Spearman’s correlations were used to determine the relationship 
between measurements. Independent-measures t-tests and Mann-Whitney tests were 
used to compare groups. Multi-group comparisons used a one-way ANOVA with 
Bonferroni correction and Kruskal-Wallis test. EGG was interpreted using the automated 
computer analysis package by Polygram (Medtronic, Inc., Shoreview, MN) for each 
channel after removing artefacts identified. Some of the ANS, EGG and cortisol data 
were not normally distributed and thus the data for nonparametric statistics are 
presented and expressed as medians and for parametric statistics presented as means 
and standard error of means. Reproducibility of the nausea study used intra-class 
correlation comparison (ICC) and agreement was measured using two-way mixed 
average measure ICC model for continuous variables. Confidence intervals for the ICC 
were calculated according to the methods of Scheffe (Green et al., 2012). ICC were 
interpreted according to suggestions made by Yen et al. as: - excellent (0.75-1), 
moderate (0.4-0.74) or poor (0-0.39) (Davis and Hallerberg, 2010). Commercially 
available statistics packages (SPSS, Chicago, IL, USA and GraphPad, San Diego, CA, 
USA) were used for the analysis. P values <0.05 were considered to be of statistical 
significance. 
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3 Results 
All subjects completed and tolerated the studies well without any vomiting. 
 
3.1 Subject characteristics 
In all, 98 healthy subjects completed the study (45 females and 53 males) with a 
median age of 23 years (range 19-58 years) and a mean body mass index (BMI) of 
22.68 kg/m2 ± 0.38kg/m2. Of the 98 subjects, 34 were Asian (34.69%), 14 were 
Orientals (14.29%), 5 were Africans (5.10%) and 45 were Europeans (45.92%). 
 
3.2 Motion vs Control video 
All subjects who completed the studies had psychometric scores consistent with healthy 
populations: big five inventory personality traits (extraversion 3.63, agreeableness 3.71, 
conscientiousness 3.67, neuroticism 2.57, openness 3.70); Spielberger trait-state 
anxiety inventory trait scores was 35.00; Weinberger questionnaire (Restrain 4.07; 
Distress 2.13; Defensiveness 2.84); Hospital Anxiety and Depression Scale (Anxiety 
4.50; Depression 1.00); motion sickness susceptibility questionnaire was 68.00% (Table 
6).  
There were no significant differences at baseline before the control or motion video for 
nausea, anxiety, cortisol, cardiac or gastric autonomic markers. But when comparing 
the percentage change from baseline for the markers after watching either video, visual 
motion induced nausea was significantly higher during motion video compared to 
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control with associated increased anxiety, sympathetic arousal, parasympathetic 
withdrawal and change from normogastria to dysrhythmias. Cortisol changes were not 
significant with both videos showing a withdrawal (Figure 26). 
  
There was a significant correlation between nausea VAS scores and MSSQ p<0.05 but 
with a correlation coefficient, r, of only 0.55 due to the wide variation in the MSSQ 
scores of the resistant subjects. 
 
 
Figure 26 Mean percentage change of motion sickness sensations from baseline in 
motion video and control video. There were significant increases in cumulative nausea, 
CN, cumulative central CC, cumulative peripheral CP and cumulative sopite CS 
sensations reported after the motion video compared to control video.  
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BASELINE MEDIANS Control 
Video 
n=98 
Motion 
Video 
n=98 
p value 
Nausea scores (VAS) 1.00 1.00 0.61 
Anxiety scores (STAI) 26.00 25.00 0.50 
CVT (LVS) 10.66 9.93 0.52 
CSB (∆RR/∆mmHg) 9.65 9.00 0.39 
HR (bpm) 64.65 64.45 0.67 
MBP (mmHg) 69.30 68.30 0.38 
SBP (mmHg) 105.70 103.60 0.88 
DBP (mmHg) 51.15 50.70 0.17 
SCR (µS) -0.09 -0.18 0.93 
Cortisol (nMol/L) 397.00 374.50 0.61 
% EGG in Normogastria (%) 73.31 75.84 0.66 
CHANGE FROM BASELINE 
MEDIANS 
Control 
Video 
n=98 
Motion 
Video 
n=98 
p value 
Nausea scores (VAS) +1.00 +2.00 <0.01 
Anxiety scores (STAI) +1.00 +7.00 <0.01 
CVT (LVS) -0.07 -0.85 <0.01 
CSB (∆RR/∆mmHg) -0.35 -1.95 <0.01 
HR (bpm) +0.65 +4.00 <0.01 
MBP (mmHg) +0.40 +3.55 <0.01 
SBP (mmHg) +1.35 +3.15 <0.01 
DBP (mmHg) +0.05 +2.90 <0.01 
SCR (µS) +0.49 +2.02 <0.01 
Cortisol(Postvideo 15 mins nMol/L) -71.00 -85.00 0.10 
% EGG in Normogastria (%) +2.46 -2.77 <0.01 
% EGG in Dysrhythmias (%) +0.20 +1.70 <0.03 
Table 6 Associated nausea markers for all subjects recruited in the study (motion video, 
MV; control video, CV). Results are medians with p values shown.  
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3.3 Gender variability in nausea susceptibility.  
Both female and male subjects who completed the studies had psychometric scores 
consistent with healthy populations however females report slightly more neuroticism 
compared to male subjects (2.86 vs 2.43 p<0.05) with no significant age differences 
between males and females. 
 
There were no significant differences at baseline for both females and males before the 
motion video for nausea, cortisol, cardiac or gastric autonomic markers but females had 
slightly higher anxiety state compared to males (26 vs 23, p<0.04). There were also no 
significant differences when comparing the percentage change from baseline after 
watching motion video between females and males. Both genders still displayed 
increased anxiety, sympathetic arousal, parasympathetic and cortisol withdrawal and 
change from normogastria to dysrhythmias. (Table 7) 
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MEDIANS Female  
MV 
n=45 
Male  
MV 
n=53 
p value 
BFI – Extraversion 3.63 3.75 0.77 
BFI – Agreeableness 4.00 3.80 0.22 
BFI – Conscientiousness 3.89 0.08 0.19 
BFI – Neuroticism 2.86 2.43 < 0.05 
BFI – Openness 3.80 3.70 0.37 
Age 22.00 23.00 0.30 
MSSQ 68.00 68.00 0.63 
STAI Trait 36.00 34.00 0.38 
BASELINE MEDIANS    
Nausea scores (VAS) 2.00 2.00 0.69 
Anxiety scores (STAI) 26.00 23.00 <0.04 
CVT (LVS) 9.54 9.98 0.83 
CSB (∆RR/∆mmHg) 9.60 8.70 0.55 
HR (bpm) 8.12 8.35 0.09 
MBP (mmHg) 66.60 69.10 0.29 
SBP (mmHg) 101.30 105.10 0.81 
DBP (mmHg) 48.70 51.10 0.09 
SCR (µS) +0.09 -0.44 0.25 
Cortisol (nMol/L) 395.00 310.00 0.15 
% EGG in Normogastria (%) 78.33 70.53 <0.04 
CHANGE FROM BASELINE 
MEDIANS 
   
Nausea scores (VAS) +2.00 +2.00 0.69 
Anxiety scores (STAI) +6.00 +9.00 0.16 
CVT (LVS) -0.83 -0.86 0.38 
CSB (∆RR/∆mmHg) -2.00 -1.60 0.80 
HR (bpm) +4.10 +3.70 0.89 
MBP (mmHg) +3.90 +2.60 0.13 
SBP (mmHg) +4.50 +1.60 0.11 
DBP (mmHg) +3.90 +1.90 0.22 
SCR (µS) +2.03 +2.02 0.34 
Cortisol(Postvideo15mins(nMol/L)) -30.00 -44.00 0.46 
% EGG in Normogastria (%) -1.03 -3.85 0.66 
% EGG in Tachygastria (%) +1.65 +1.93 0.81 
Table 7 Personality (Big Five Inventory, BFI) and Motion sickness susceptibility 
questionnaire (MSSQ) scores for female and male subjects recruited in the study 
(motion video, MV; control video, CV; nausea susceptible, NS; nausea resistant, NR). 
Results are medians with significant differences marked with an asterix and p values 
shown.  
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3.4 Ethnic variability in nausea susceptibility.  
The 34 Asians and 14 Chinese were grouped together as Asians. Both Asians and 
European subjects who completed the studies had psychometric scores within the 
normal range however Europeans scored slightly more for extraversion, neuroticism 
and openness compared to Asian subjects (Table 8). 
 
There were no significant differences at baseline for both Europeans and Asians before 
the motion video for nausea, cortisol, cardiac or gastric autonomic markers. No 
significant differences were also seen when comparing the percentage change from 
baseline after watching motion video between Europeans and Asians except systolic 
blood pressure was increased more in Europeans. Both genders still displayed 
increased anxiety, sympathetic arousal, parasympathetic and cortisol withdrawal and 
change from normogastria to dysrhythmias. (Table 8). 
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MEDIANS Asian  
MV 
n=48 
European 
MV 
n=50 
p value 
BFI – Extraversion 3.38 3.75 < 0.05 
BFI – Agreeableness 3.80 3.90 0.31 
BFI – Conscientiousness 3.56 3.83 < 0.05 
BFI – Neuroticism 2.57 2.64 0.66 
BFI – Openness 3.70 3.80 < 0.05 
Age 23.00 23.23 0.55 
MSSQ 14.80 17.50 0.42 
STAI Trait 36.00 32.00 < 0.01 
BASELINE MEDIANS    
Nausea scores (VAS) 2.00 1.50 0.15 
Anxiety scores (STAI) 26.00 25.00 0.18 
CVT (LVS) 9.05 10.49 0.65 
CSB (∆RR/∆mmHg) 8.90 9.25 0.44 
HR (bpm) 66.50 62.45 0.14 
MBP (mmHg) 68.30 68.25 0.66 
SBP (mmHg) 104.70 102.10 0.56 
DBP (mmHg) 50.40 50.75 0.83 
SCR (µS) -0.32 -0.06 0.98 
Cortisol (nMol/L) 395.00 310.00 0.15 
% EGG in Normogastria (%) 74.98 77.29 0.19 
CHANGE FROM BASELINE 
MEDIANS 
   
Nausea scores (VAS) +2.00 +1.50 0.15 
Anxiety scores (STAI) +10.00 +7.00 0.65 
CVT (LVS) -1.24 -0.68 0.48 
CSB (∆RR/∆mmHg) -2.10 -1.45 0.47 
HR (bpm) +3.15 +4.40 0.80 
MBP (mmHg) +3.55 +3.55 0.09 
SBP (mmHg) +2.15* +3.7* <0.05 
DBP (mmHg) +2.55 +3.30 0.28 
SCR (µS) +1.91 +2.09 0.76 
Cortisol(Postvideo15mins(nMol/L)) -46.50 -35.00 0.95 
% EGG in Normogastria (%) -3.09 -2.66 0.49 
% EGG in Tachygastria (%) 1.90 1.70 0.39 
Table 8. Personality (Big Five Inventory, BFI) and Motion sickness susceptibility 
questionnaire (MSSQ) scores for subjects recruited in the study (motion video, MV; 
control video, CV; nausea susceptible, NS; nausea resistant, NR). Results are medians 
with significant differences marked with an asterix and p values shown.  
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3.5 Variability in nausea susceptibility.  
Subjects who fell within the 1st quartile did not report any nausea when exposed to the 
stimulus and were grouped as nausea resistant (NR) subjects. Subjects who fell within 
the 4th quartile and reported at least moderate to severe nausea were grouped as 
nausea susceptible (NS) subjects. There were 28 who were NS, 28 who were 
Intermediates and 42 were NR (Figure 27). When 25 of the most nausea susceptible 
and 25 of the most resistant of these groups are compared, nausea susceptible 
subjects reported significantly higher nausea and scored significantly higher on the 
MSSQ compared to NR subjects. When subjects were divided into nausea susceptible 
and nausea resistant both CVT and CSB decreased in the susceptible subjects during 
the motion video with increased heart rate and blood pressures. Cortisol was 
significantly higher in nausea susceptible in comparison with nausea resistant subjects 
(Table 9). There were decreased normal gastric rhythms with dysrhythmias shown more 
clearly; this is illustrated in figure 7 with a single susceptible volunteer’s real time EGG 
tracings showing a clear shift from the baseline fasting normal 3 cycles per minute 
(cpm) to increased dysrhythmias during the motion video which was  associated with 
severe nausea. 
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Figure 27. Nausea scores during the nausea stimuli for nausea susceptible & resistant 
subjects Study 1. All susceptible subjects had moderate scores and up to severe 
nausea during the motion video. Meanwhile, all resistant subjects had no nausea during 
the motion video. 
 
Figure 28. Gastric myoelectrical activity shown together with an example of with a single 
volunteer’s real time EGG tracings. 
  
 114 
 
MEDIANS NR MV 
n=25 
NS MV 
n=25 
p value 
BFI – Extraversion 66.00 68.00 0.70 
BFI – Agreeableness 76.00 68.00 0.07 
BFI – Conscientiousness 69.00 61.00 0.08 
BFI – Neuroticism 37.00 42.00 0.37 
BFI – Openness 68.00 69.00 0.70 
Age 24.00 25.00 0.92 
MSSQ 46.00 80.00 0.06 
STAI Trait 34.00 35.00 0.23 
BASELINE MEDIANS Control 
Video 
n=98 
Motion 
Video 
n=98 
p value 
Nausea scores (VAS) 1.00 1.00 0.67 
Anxiety scores (STAI) 25.00 25.00 0.41 
CVT (LVS) 10.83 10.60 0.55 
CSB (∆RR/∆mmHg) 9.80 9.60 0.47 
HR (bpm) 63.40 63.30 0.51 
MBP (mmHg) 67.70 67.80 0.80 
SBP (mmHg) 105.40 105.10 0.61 
DBP (mmHg) 49.80 49.50 1.00 
SCR (µS) -0.01 -0.93 0.83 
Cortisol (nMol/L) 505.50 298.00 <0.05 
% EGG in Normogastria (%) 75.00 74.00 0.60 
CHANGE FROM BASELINE MEDIANS    
Nausea scores (VAS) +0.50* +2.80* < 0.01 
Anxiety scores (STAI) +3.12* +11.34* < 0.01 
CVT (LVS) - 5.03* - 20.63* < 0.01 
CSB (∆RR/∆mmHg) - 7.08* - 27.64* < 0.01 
HR (bpm) +4.52* +11.05* < 0.01 
MBP (mmHg) +2.69* +7.73* < 0.05 
SBP (mmHg) +1.47* +5.67* < 0.05 
DBP (mmHg) +4.12* +9.94* < 0.05 
SCR (µS) +0.51* +2.15* <0.01 
Cortisol(Postvideo15mins(nMol/L) - 21.93* +17.94* < 0.05 
% EGG in Normogastria (%) +1.60* -2.82* < 0.01 
% EGG in Dysrhythmias (%) +0.83* +2.35* < 0.05 
Table 9. Personality (Big Five Inventory, BFI) and Motion sickness susceptibility 
questionnaire (MSSQ) scores for subjects recruited in the study (motion video, MV; 
control video, CV; nausea susceptible, NS; nausea resistant, NR). Results are medians 
with significant differences marked with an asterix and p values shown.  
 
 115 
 
3.6 Reproducibility of the Nausea Study 
3.6.1 Subject Characteristics 
Twenty healthy subjects were recruited to the study (12 male) with a median age of 24.3 
years (range 21-33 years) and a mean BMI of 21.3 kg/m2 ± 0.78 kg/m2. Of the 20 
subjects, 10 were Caucasian (50%), 2 Afro-Caribbean (10%), 3 were Asian (15%), and 
5 were Orientals (25%). 
 
3.6.2 Reproducibility of Nausea Study 
The similar changes are observed for the 20 subjects who repeated their studies with 
significantly more nausea and anxiety and the same associated markers changes 
(Table 10). The mean ± SEM and inter-class correlation (ICC) for each of the markers 
are summarised in Table 11. The baselines of all markers were consistent between 
study 1 and 2. The reproducibility of nausea parameters at baselines was moderate to 
good with ICCs between 0.52 to 0.89 indicates that there was no bias or systematic 
error. Participants’ ratings of MSAQ, STAI, % EGG in Normogastria, HR and SCR in 
response to the motion video were higher in comparison to baseline in both study 1 and 
2.  The reproducibility was good for STAT, HR and SCR with ICCs of 0.81, 0.82 and 
0.88, respectively, and moderate reproducibility for MSAQ, and % EGG in Normogastria 
with ICCs of 0.57 and 0.40 respectively. The nausea score, SBP, MBP and DBP levels 
increased moderately above the baseline after watching the motion video and had good 
reproducibility with ICCs of 0.81, 0.74, 0.69 and 0.53 respectively.  In contrast, 
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participants’ rating of % EGG Normogastria, CVT and CSB dropped below the baseline 
in both study 1 and 2 in response to the motion video and had reproducibility with ICCs 
of 0.55 (moderate), 0.87 and 0.73 (good), respectively.   
 
Table 10. Mean baseline, control and motion video at baseline. 
 
  
Variable	   Baseline	  
Control:	  
Mean	  
(±SEM)	  
Baseline	  
Nausea:	  
Mean	  
(±SEM)	  
Control	  
Video:	  
Mean	  
(±SEM)	  
Nausea	  
Video:	  Mean	  
(±SEM)	  
Baseline	  
Control	  vs.	  
Baseline	  
Nausea	  
Video	  
Control	  vs.	  
Nausea	  
Video	  
HR	  (bpm)	   64.95	  ±	  0.92	   64.64	  ±	  
0.89	  
65.68	  ±	  
0.90	  
68.82	  ±	  1.00	   p=0.67	   p<0.01	  
SBP	  (mmHg)	   104.80	  ±	  
1.19	  
104.63±	  
1.25	  
106.11	  ±	  
1.24	  
109.70	  ±	  1.47	   p=0.88	   p<0.01	  
DBP	  (mmHg)	   52.18	  ±	  0.65	   51.26	  ±	  
0.63	  
52.49	  ±0.71	   54.49	  ±	  0.81	   p=0.17	   p<0.01	  
MBP	  (mmHg)	   69.69	  ±	  0.75	   69.03±	  0.75	   70.34	  ±	  
0.81	  
72.86	  ±	  0.95	   p=0.38	   p<0.01	  
CVT	  (LVS)	   11.35	  ±	  0.46	   11.67	  ±	  
0.57	  
11.18±	  0.50	   10.08	  ±	  0.49	   p=0.51	   p<0.01	  
CSB	  (BRS)	  
(ΔRR/ΔmmHg
)	  
10.16	  ±	  0.40	   10.6	  ±	  0.54	   9.97	  ±	  0.42	   8.81±	  0.40	   p=0.39	   p<0.01	  
SCR	  (μS)	   -­‐0.04	  ±	  0.26	   -­‐0.004	  ±	  
0.36	  
1.24	  ±	  0.38	   2.95	  ±	  0.49	   p=0.93	   p<0.01	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   Baseline	   Motion	  Video	  
Variable	   Study	  1	  
Mean	  
(±SEM)	  
Study	  2	  
Mean	  
(±SEM)	  
ICC	  (95%	  
confidence	  
interval)	  
Study	  1	  
Mean	  
(±SEM)	  
Study	  2	  
Mean	  (±SEM)	  
ICC	  (95%	  
confidence	  
interval)	  
	  
Nausea	  Score	   1.00	  ±	  0.23	   1.00	  ±	  0.18	   0.89	   1.93	  ±	  0.23	   1.73	  ±	  0.18	   0.81	  
MSAQ	  Score	   5.00	  ±	  0.24	   5.00	  ±	  0.25	   0.57	   9.05	  ±	  1.01	   8.2	  ±	  0.90	   0.57	  
STAI	  State	   26.6	  ±	  0.75	   23.7	  ±	  1.32	   0.85	   36.08	  ±	  
1.20	  
31.28	  ±	  3.37	   0.61	  
%	  EGG	  in	  
Normogastria	  
72.10	  ±	  1.51	   77.23	  ±	  
2.76	  
0.52	   69.29	  ±	  
3.58	  
68.78±	  3.27	   0.55	  
%	  EGG	  in	  
Tachygastria	  
6.04	  ±	  1.62	   5.10	  ±	  1.51	   0.67	   8.43	  ±	  1.74	   9.78	  ±	  2.96	   0.40	  
HR	  (bpm)	   62.44	  ±	  1.62	   61.01	  ±	  
1.67	  
0.81	   66.76±	  1.74	   64.97	  ±	  1.75	   0.82	  
SBP	  (mmHg)	   102.41±	  
2.83	  
104.74±	  
2.58	  
0.79	   105.64	  ±	  
2.90	  
104.87	  ±	  2.92	   0.74	  
DBP	  (mmHg)	   49.92±	  1.78	   49.32	  ±	  
1.14	  
0.71	   53.46	  ±	  
1.35	  
51.92	  ±	  1.61	   0.53	  
MBP	  (mmHg)	   67.39±	  1.55	   67.78	  ±	  
1.42	  
0.73	   70.83±	  1.70	   68.30	  ±	  1.52	   0.69	  
CVT	  (LVS)	   10.30	  ±	  0.77	   11.82	  ±	  
1.18	  
0.73	   9.18	  ±	  0.74	   9.87	  ±	  0.92	   0.87	  
CSB	  (BRS)	  
(ΔRR/ΔmmHg)	  
8.9	  ±	  0.78	   10.14	  ±	  
1.01	  
0.73	   7.51±	  0.61	   8.66±	  0.9	   0.73	  
SCR	  (μS)	   1.49	  ±	  0.90	   0.91	  ±	  0.87	   0.84	   4.22	  ±	  1.26	   3.80	  ±	  1.19	   0.88	  
Table 11. The reproducibility of nausea study parameters at baseline and following 
motion video.	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4 DISCUSSION 
4.1 Motion versus control video 
The results show that nausea video is able to provoke nausea in more than half (57%) 
of all the subjects with a range of responses, and more importantly nausea sensations 
receded quickly within five minutes post-stimulus. The nausea video also produced 
classical changes in markers associated with nausea for all subjects, like the withdrawal 
of parasympathetic activity and cortisol with sympathetic arousal. The percentage of 
time with EGG in normal gastric rhythm was also reduced during motion versus control 
video with an increase in dysrhythmias (e.g., increase in tachygastrias and 
arrhythmias). The presence of increased anxiety during the control video may be due to 
the anticipation of a nauseogenic stimulus (Jacobsen et al., 1988). While there was an 
increase of state anxiety during nausea video, this study is unable to conclude whether 
the elevated anxiety level is the indirect result or cause of nausea experienced by the 
subjects. Considering previous reports on the correlation between elevated trait and 
state anxiety and anticipatory nausea and vomiting in cancer patients receiving 
chemotherapy (Andrykowski, 1990), it is likely that anxiety plays an important role in 
nausea development. 
 
In general, the results from my study does not show that Asians or Chinese were more 
susceptible to nausea compared to other ethnicities (Stern et al., 1993) nor were there 
any gender or personality subclass differences (Turner and Griffin, 1999). The females 
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in this study did score slightly more for neuroticism personality trait as well as higher 
baseline anxiety compared to the males. 
 
The reproducibility of the markers at study visits one year apart for visual motion 
induced nausea appear to be stable in a representative cohort of 20 out of the original 
98 subjects studied. There is good reproducibility of the nausea VAS scores with 
moderate ICC for the more detailed MSAQ scores with scores mainly differing in the 
three other dimensions of motion sickness rather than nausea complaints (Golding 
2006). This is also consistent with a postoperative nausea and vomiting study where the 
PONV Intensity Scale showed 0.99 ICC. The reproducibility of EGG was poor to 
moderate and this probably reflects the sensitivity of the EGG to noise although a study 
measuring dominant power and frequency daily while fasting over three days showed 
there was no significant difference with analysis of variance. 
 
4.2 Selecting nausea susceptible versus resistant subjects 
In the comparison between susceptible and resistant subjects, nausea scores were 
positively correlated with the higher mean percentage motion sickness susceptibility of 
NS subjects, while the median MSSQ scores for NS vs NR subjects showed a trend 
towards higher scores in those who were nausea susceptible. The MSSQ may 
potentially predict a moderate to severe nausea reactivity to the motion video if the 
subjects score highly that is similar with previous findings (Golding, 1998). 
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Susceptible subjects withdrew parasympathetic activity and cortisol with sympathetic 
arousal. The percentage of time with EGG in normal gastric rhythm was also reduced 
during motion versus control video with an increase in dysrhythmias (e.g., increase in 
tachygastrias and arrhythmias).  
 
Cardiac sympathetic arousal during nausea are similar to responses in ‘fight or flight’ 
situations and are consistent with findings from previous studies of vection (Himi et al., 
2004, Cowings et al., 1986). The cardiac parasympathetic withdrawal (CVT, CSB) 
during the stimulus was also in-line with previous reports (Himi et al., 2004, Cowings et 
al., 1986). Contrary to previous findings (Parker and Wilsoncroft (Parker and 
Wilsoncroft, 1978b, Himi et al., 2004), baseline sympathetic and parasympathetic 
responses do not seem to influence the manifestation of nausea in this group of 
subjects as this study found no significant differences in those parameters between 
susceptible and resistant subjects.  
 
Susceptible subjects had a lower baseline cortisol compared to resistant subjects that is 
consistent with previous findings although the expected rise in cortisol was not seen in 
this study (Koch KL, 1985, Otto et al., 2006). This might be due to the fact that this is a 
milder stimulus compared to actual motion and thus less stressful. The parasympathetic 
activity could be a form of innate protective mechanism however another study has 
shown interesting observations of high baseline parasympathetic tone leading to 
increased nausea susceptibility (Rawat et al., 2002).  
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The EGG results above are consistent with previous studies (Imai et al., 2006) however 
the dominant frequency and dominant power were not significantly increased possibly 
due to the multiple assessments done simultaneously that would increase subject 
movement and as EGG is a very weak signal and sensitive to noise, this would make it 
difficult to get accurate readings (Stern et al., 1985, Muth et al., 1995).  
 
4.3 Limitations and future work 
In summary, the study showed that the virtual reality video human model of nausea is a 
good and safe stimulus for studying nausea comprehensively without vomiting with 
multiple modalities of recordings. The stimulus was chosen for its safety profile and may 
not be generalised for other conditions although there some evidence that susceptibility 
to nausea from motion sickness may potentially predict susceptibility to nausea in 
chemotherapy patients and physically-induced motion sickness (Golding, 2006). As 
there are no comprehensive studies of nausea especially one that is adaptable for brain 
imaging, this is the most suitable stimulus currently available and the subjects identified 
as susceptible and resistant in this study are potentially good candidates for a functional 
brain imaging study (Stern et al., 2011). 
 
Visual motion induced nausea has the weakness of other collinear presentations of 
nausea with the previous observation of several dimensions of sensations closely linked 
to it (Muth et al., 1996, Gianaros et al., 2001). The three observed before are central, 
peripheral, sopite sensations (Gianaros et al., 2001). It is also closely linked with anxiety 
 122 
 
as it causes general discomfort and is stressful (Burish and Carey, 1986, Haug et al., 
2002). However, in this study the effects of the stimulus may be due to nausea because 
of no correlations between the nausea scores and other related motion sickness 
sensations, low BFI neuroticism score and low STAI state and trait scores in all 
subjects. 
 
Another limitation to consider is that all the investigations are indirect assessments of 
the systems involved and may not be truly representative of the cortical processing of 
nausea. This is where there is a need for functional brain imaging studies to be able to 
decipher better the associated nausea markers that sometimes provides conflicting 
results (Stern et al., 2011).  
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1 Introduction 
The human studies specifically studying nausea genesis in the brain include a 1996 
magnetic source imaging study whereby one subject underwent yaw-axis rotations with 
side-to-side head movements and ipecac ingestion showing inferior frontal gyrus 
activation (Miller et al., 1996). This activation was reversed when the same subject was 
administered the anti-emetic drug ondansetron, a 5-hydroxytryptamine3 receptor 
antagonist. These results supported an older 1993 electro-encephalography study 
which demonstrated increased activity in the temporo-frontal region during motion 
sickness (Chelen et al., 1993). The inferior frontal gyrus was also activated by galvanic 
vestibular stimulation (Bense et al., 2001, Stephan et al., 2005) caloric vestibular 
stimulation (Fasold et al., 2002) without nausea in human fMRI studies. Galvanic 
stimulation also activated the basal ganglia, inferior and middle frontal gyrus, 
parahippocampal gyrus and hippocampus (limbic), cerebellum (crus I, vermal lobule IV), 
anterior and posterior insula and retroinsular regions (interoception and visceral 
autonomic response), superior temporal gyrus, temporoparietal cortex, precentral gyrus, 
thalamus, anterior cingulate gyrus, and the supplementary motor area (Bense et al., 
2001, Stephan et al., 2005). More recently, an fMRI study of visual motion induced 
nausea on 28 women discovered that there were also activation of the dorsolateral 
prefrontal cortices bilaterally and in addition a broader network involving the 
interoceptive, limbic, somatosensory brain regions were also stimulated (Napadow et 
al., 2012b). Activation of the insula and cingulate cortices have also been shown to play 
an important role in animal and other related human studies (Stern et al., 2011). There 
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is now a need for a larger functional magnetic resonance imaging (fMRI) study of a 
similar design to Miller et al., (1996) with a balanced recruitment of both men and 
women (Napadow et al., 2012b) using preselected subjects who are susceptible with 
resistant subjects for comparison (Stern et al., 2011), with a safe stimulus (Kowalski et 
al., 2006)  that allows for repeat volunteer visits. 
 
1.1 Functional Magnetic Resonance Imaging 
The fMRI has excellent spatiotemporal resolutions, can exhibit whole brain networks 
while subjects are stimulated, and subjects are not exposed to harmful materials (Aziz 
and Thompson, 1998). Thus it is preferred over magnetoencephalography (MEG), 
computed tomography (CT) and positron emitting tomography (PET). The investigation 
of the cortical pathways involved in nausea genesis may potentially uncover new targets 
as well as form the basis for quantitative pharmacological studies of nausea (Borsook et 
al., 2006a). This is important for the clinical management of nausea especially those 
seen in postchemotherapy patients as it is currently the target of oncological societies to 
control of nausea, the greatest remaining emetogenic challenge (Roila et al., 2010). 
This neuroimaging technique measures changes in the blood oxygenation levels in 
microcirculation that provides an indirect measure of neural activity. Neural activity 
increases blood supply to the surrounding capillary beds overcompensating for neural 
oxygen consumption causing an increase in oxyhaemoglobin and decrease in 
deoxyhaemoglobin concentration. Oxyhaemoglobin is less paramagnetic than 
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deoxyhaemoglobin causing the magnetic resonance (MR) signal intensities to change 
i.e. increased oxyhaemoglobin concentrations leads to higher MR signals. A net 
increase in MR signal intensity (usually about 0.5–5% in magnitude) is thus detected 
and is dependent on the amount increased blood flow evoked that correlates with 
increased neural activity (Logothetis, 2008, Raichle and Mintun, 2006).   
 
Figure 29. BOLD fMRI measures changes in the blood oxygenation levels in the 
microcirculation providing an indirect measure of neural activity. Brain activity increases 
blood flow to the surrounding capillary beds overcompensating for neural oxygen 
consumption causing an increase in oxyhaemoglobin and decrease in 
deoxyhaemoglobin concentration. As oxyhaemoglobin is less paramagnetic than 
deoxyhaemoglobin, the magnetic resonance (MR) signal intensities change i.e. 
increased oxyhaemoglobin concentrations leads to higher MR signals. A net increase in 
MR signal intensity (usually about 0.5–5% in magnitude) is thus detected and is 
dependent on the amount increased blood flow evoked that correlates with increased 
neural activity (Logothetis, 2008, Raichle and Mintun, 2006).   
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1.2 Knowledge gaps 
Whilst there have been numerous studies of nausea using multiple animal models, this 
is somewhat inadequate in the evaluation of a subjective, descriptive experience of 
nausea, especially when comparing animals with such differing neuroanatomy (Hermer 
and Spelke, 1994, Hermer and Spelke, 1996).  Progress in the understanding of the 
neurophysiological mechanisms of nausea, is hindered by a scarcity of human brain 
imaging studies to evaluate the brain processing of nausea (Stern et al., 2011). Thus, 
there is a need to delineate the specific areas of the brain generating nausea better in 
humans. 
 
1.3 Research aims and hypothesis 
The aim of the present study was to use the previously validated methods now to study 
the brain processing of nausea and compare brain activity in susceptible and resistant 
subjects. I hypothesise that subjects preselected by previous exposure to the stimulus 
as either susceptible or resistant will show differences in the brain processing of 
nausea. 
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2 Method 
2.1 Study design and setting 
This was a crossover study i.e. the same subject is exposed to both a control and 
experimental condition. It was carried out at the Institute of Psychiatry, King’s College 
London (KCL). 
 
2.2 Ethical approval 
The King’s College London Research Ethics Committee (PNM/09/09-04) approved 
these studies. 
 
2.3 Subjects 
30 healthy right handed volunteers from the Chapter 3 study were invited for this study: 
17 nausea susceptible (8 males and 9 females) median age 24 years, range 19 - 34 
years, and 11 nausea resistant (6 males and 5 females) median age 22 years, range 20 
- 33 years were preselected based upon previous exposure to the stimulus. All subjects 
gave written informed consent. Volunteers were recruited to meet the following criteria: 
(i) normal body mass index, (ii) no abnormality on clinical examination, including a 
history or presence of cardiac, ophthalmologic, gastro-intestinal, hepatic, or renal 
disease, or other condition known to alter their response to visually induced motion 
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sickness nausea e.g. vestibular disease, (iii) no abnormality on electrocardiogram 
examination at screening (iv) no abuse of alcohol (defined as an average intake >21 
units per week or 3 units per day); and (v) no history or presence of neurological or 
psychiatric conditions (e.g. stroke, traumatic brain injury, epilepsy, space-occupying 
lesions, multiple sclerosis, Parkinson’s disease, vascular dementia, transient ischaemic 
attack, schizophrenia, major depression, etc). Subjects with any of the following were 
excluded: (i) received prescribed medication within 14 days prior to the first visit, which 
might interfere with the study procedures or compromise safety, (ii) received over-the-
counter medicine within 48h of the study, (iii) participated in a trial with any drug within 3 
months before the first visit, (iv) had a caffeinated drink within 24 h of visit. 
 
2.4 Materials and Protocol 
After the same preparation as the protocol for Chapter 3 study, with the addition of MRI 
safety measures, the subjects were brought into the MRI room. Subjects were provided 
with a pair of goggles with questionnaires administered assessing nausea (VAS and 
MSAQ) and anxiety (STAI-state). After starting motion or control video, minute-to-
minute nausea reporting using a four button box with first button for no nausea and then 
mild, moderate and last button for severe nausea was collected during the fMRI scans. 
Blood samples were not taken during this study. 
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Figure 30. Schematic summary of chapter 4 experimental protocol: After 6 hours of 
fasting subjects arrived for chapter 4 answering questionnaires which e.g. assess 
motion sickness symptoms and questionnaires which e.g. assess motion sickness 
symptoms and, reassessed just before starting motion or control video after which 
minute to minute nausea reporting was determined and another MSAQ and STAI-S 
questionnaire were adminstered at the end of the video. This is essentially similar with 
study 1 protocol with the exception that no bloods being taken. 
 
2.5 Baseline activity 
Subjects were encouraged to relax and focus on a target presented in the goggles for 
two and a half minutes before the video is started. This forms the baseline recordings. 
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2.6 Assessment of motion sickness susceptibility and anxiety 
levels 
Subjects used a button box (four button box with first button for none and then mild, 
moderate and last button for severe) on their right hands to self-report nausea and 
anxiety scores before and at the end of each video as well as nausea scores every 
minute during the video. The ratings were reported using the same visual analogue 
scale used during study 1 explained above. Both MSAQ and STAI-S questionnaires 
were also administered just before and at the end of the videos. A two-way, random 
effects, average measures intra-class correlation (ICC) model for continuous variables 
were calculated between the chapter 3 and 4 visits for the 28 subjects (Green et al., 
2012) to assess reproducibility of their nausea induction. Please refer Chapter 2 section 
2.4.6 for more details. 
 
2.7 Exposure to stimulus 
Subjects watched two different videos consecutively through a pair of MRI compatible 
goggles provided as standard equipment by the MRI manufacturer. The goggles are 
positioned with rubber eyepieces to cover their eyes to limit their field of view to only the 
screen and delivered the stimulus using two LCD screens in front of each eye to create 
an illusion of a large screen in front of them: 
. The videos consisted of; 
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§ a non-nausea inducing video consisting of a stationary cityscape (control or neutral 
video) and 
§ a nausea inducing video consisting of a moving cityscape (nausea video)  
The first and second videos were separated by a washout period of 10 minutes during 
which subjects continued to be questioned every minute for symptoms of nausea, 
anxiety or dizziness until no symptoms are reported. This was to avoid a carry-over 
effect of symptoms from one video onto another. A red target was put in the video at 
regular intervals to assess the subject’s attention on the video, as shown in Figure 3. 
 
Figure 31. The novel stimulus - projected in front of a subject with goggles to limit their 
peripheral vision to the stimulus.  The off-vertical tilt helps create an illusion that the 
subject was actually spinning, at an angle which is found to hasten the onset of MSIN 
(Bijveld et al., 2008b) 
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2.8 Subjective monitoring 
A visual-analogue-scale symptoms (VAS) questionnaire and motion sickness 
assessment questionnaire (MSAQ) described in chapter 2 section 2.4.7 documented 
any symptoms reported by the subjects. A visual scale from 1 to 4 was used with 1 
being, without symptom, and 2 being mild symptom, 3 being moderate symptoms and 4 
being maximum level of tolerated symptom. State anxiety status was assessed using 
the state version of the STAI. 
 
2.9 Objective monitoring 
The SCR was recorded on the subject’s left hand continuously throughout the 
experiment. Cardiac pulse and respiratory effort data were monitored using a pulse 
oximeter (InVivo) and a respiratory effort transducer (BIOPAC), respectively. The pulse 
oximeter was placed on the subject’s left index finger. The respiratory effort belt was 
placed around the subject’s abdomen. The vital signs monitoring was performed similar 
to those described in chapter 2. Video was delivered through fMRI compatible goggles 
with an eye-tracker video to monitor subject’s attention to the stimulus and pupil location 
(NordicNeuroLab GmbH VisualSystem, Norway). 
The fMRI data (T2*-weighted images) was collected on a General Electric Signa Excite 
II 1.5 T HD scanner based at the Centre for Neuroimaging Sciences, Institute of 
Psychiatry, King’s College London. Head movement was restricted using foam padding 
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within the head coil and an eye movement’s tracker was mounted onto the head coil 
together with the in-built MRI compatible goggles delivering the stimulus. Prior to the 
start of the fMRI experiment, a high-resolution gradient echo structural scan (43x3mm 
slices, 0.3 interslice gap, TE 40ms, TR 3000ms, flip angle 90˚, matrix 128², in plane 
voxel dimensions 1.875x1.875) was acquired in each volunteer to be used for Talairach 
normalisation. During fMRI, a total of 300 T2* weighted images per slice (40x3mm 
slices, 0.3 interslice gap, TE 25ms, TR 3500ms, flip angle 90˚, matrix 64²), depicting 
blood oxygen level dependant (BOLD) contrast were collected as subjects viewed the 
control and motion video.   
 
2.10 Statistical analysis  
XBAM version 4.1 (http://brainmap.co.uk/ referenced on the 8th of August 2012), a 
package developed at the Institute of Psychiatry, King’s College London, was used to 
analyse fMRI data. It implements permutation-based nonparametric methods to 
minimise the number of assumptions used in making statistical inference (Brammer et 
al., 1997). After acquisition, fMRI data pre-processing, smoothing and individual brain 
activation mapping was performed (Coen et al., 2009). Analysis of covariance was 
performed on the effect size maps in Talairach and Tournoux’s standard space 
(Talairach and Tournoux, 1988) with each voxel statistic corrected for the actual number 
of participants contributing to the calculation (Thirion et al., 2007). An analysis of 
covariance (ANCOVA) examining the main effect of several different groups on whole-
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brain neural activity was done and a clusterwise p value of 0.01 (corrected for whole 
brain volume using permutation testing). Correlation analysis for brain activity to the 
level of nausea reported were analysed during the nausea video. Comparisons were 
also made between activity in the whole brain for all subjects between control versus 
motion video and between resistant versus susceptible subjects during the motion 
video.  
Psychometric, nausea questionnaires, and autonomic data were analysed using 
matched-pair t-tests and Wilcoxon tests to compare the means and medians. Pearson’s 
and Spearman’s correlations were used to determine the relationship between 
measurements. Independent-measures t-tests and Mann-Whitney tests were used to 
compare groups. Reproducibility of the studies used intra-class correlation comparison 
(ICC) and agreement was measured using two-way mixed average measure ICC model 
for continuous variables. Confidence intervals for the ICC were calculated according to 
the methods of Scheffe (Green et al., 2012). ICC were interpreted according to 
suggestions made by Yen et al (2002) as: - excellent (0.75-1), moderate (0.4-0.74) or 
poor (0-0.39) (Davis and Hallerberg, 2010). Commercially available statistics packages 
(SPSS, Chicago, IL, USA and GraphPad, San Diego, CA, USA) were used for the 
analysis. P values <0.05 were considered to be of statistical significance. 
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3 RESULTS 
All 30 subjects completed and tolerated the studies well without any vomiting or 
retching. 2 subjects’ (1 nausea susceptible and 1 nausea resistant) data were 
excluded from analysis due to excessive motion artefact (>3mm translation in 
any axis or spiking >1.5mm) or scanner anxiety.  
 
3.1 Response to videos  
The 17 nausea susceptible subjects reported significantly higher nausea compared to 
the 11 resistant subjects during the motion video (Figure 32). The susceptible subjects 
reporting more nausea also reported more anxiety on the STAI compared to the 
resistant subjects who did not report much nausea (+7 vs +1, p<0.05). The 17 
susceptible subjects’ nausea responses during the motion video when compared to the 
initial visit responses had an ICC of 0.539 with a slight reduction of reported nausea 
percentage change compared to baseline during the motion video (-5.3% ± 1.1, 
p>0.05).  
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Figure 32. Nausea scores during the fMRI motion video for 17 nausea susceptible and 
11 nausea resistant subjects. All 17 nausea susceptible subjects experienced a gradual 
increase in nausea scores during the motion video with statistically significant peaking 
at the end of the video (p<0.05). Meanwhile the 11 nausea resistant subjects did not 
have any nausea or had mild nausea during the motion video. 
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3.2 Control versus motion video for all subjects 
All 28 subjects demonstrated an increase in activity in the right middle temporal gyrus 
and the left occipital lobe cuneus (Table 12); and a decrease in activity in the left 
parahippocampal gyrus and the right cerebellar tonsil while watching the motion video 
compared to watching the control video (Table 13). 
Cerebral Region 3D Cluster size Peak Talairach Coordinates (x, y, z) Probability 
Right Middle 
Temporal Gyrus 63 43.33, -59.26,  -3.30 0.0039 
Left Occipital 
Lobe Cuneus 921 -18.06, -74.07,   9.90 0.0001 
Table 12. Brain activity in all subjects during control vs motion video. There was 
increased activity in these brain areas during motion video compared to control video in 
all 28 subjects. 
 
Cerebral Region 3D Cluster size Peak Talairach Coordinates (x, y, z) Probability 
Left 
Parahippocampal 
Gyrus 
54 -21.67, -25.93, -13.20 0.0034 
Right Cerebellar 
Tonsil 107 3.61, -55.56, -39.60 0.0006 
Table 13. Brain activity in all subjects during control vs motion video. There was 
decreased activity in these brain areas during motion video compared to control video in 
all 28 subjects. 
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3.3 Nausea susceptible versus nausea resistant subjects 
Nausea susceptible subjects demonstrated an increased in activity in right substantia 
nigra (Peak Talairach Coordinates (x, y, z) 3.61, -18.52, 16.50; <p = 0.01) compared to 
resistant subjects during the nausea stimulus (Figure 33) and decrease in activity in left 
cerebellar declive and right parahippocampal gyrus (Table 14). 
 
 
Figure 33. Brain activity in susceptible 
subjects vs resistant subjects during 
nausea video. Red spots marks the 
increased activity in the substantia nigra in 
17 nausea susceptible subjects compared 
to 11 resistant subjects during the nausea 
video. 
 
 
 
Cerebral Region 3D Cluster size 
Peak Talairach 
Coordinates (x, y, z) Probability 
Left Cerebellar 
Declive 197 
-10.83, -66.67, -
13.20 0.0012 
Right 
Parahippocampal 
Gyrus 
66 21.67, -44.44, -6.60 0.0034 
Table 14.  Brain activity in susceptible subjects vs resistant subjects during nausea 
video. There is decreased activity these brain areas in 17 nausea susceptible subjects 
compared to 11 resistant subjects during the nausea video. 
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3.4 Correlations between nausea scores and brain activity:  
Nausea scores also positively correlated with left inferior frontal gyrus (Peak Talairach 
Coordinates (x, y, z) -54.17, 25.93, -6.60; <p = 0.01) activity ( 
Figure 34 and Figure 35) where activity increased with increasing scores of nausea. 
Nausea scores negatively correlate with right occipital cuneus, left anterior cerebellar 
culmen, left occipital lingual gyrus, right parahippocampus and left posterior cerebellar 
declive activity for susceptible subjects (Table 15). 
Cerebral Region  3D Cluster size 
Peak Talairach 
Coordinates (x, y, z) Probability 
Right Occipital 
Cuneus 79 7.22, -70.37, 13.20 0.0005 
Left Anterior 
Cerebellar 
Culmen 
38 
 
-7.22, -51.85, -3.30 
 
0.0016 
Left Occipital 
Lingual Gyrus 151 -3.61, -70.37, -3.30 0.0001 
Right 
Parahippocampus 70 21.67, -25.93, -13.20 0.0006 
Left Posterior 
Cerebellar Declive 64 -32.50, -51.85, -13.20 0.0005 
Table 15. Brain activity correlated with nausea scores. There was decreased activity in 
these brain areas that is correlated with decreased reporting of nausea scores in 17 
nausea susceptible subjects during the nausea video. 
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Figure 34.  Brain activity correlated with nausea scores. Red spots mark the increased 
activity in the inferior frontal gyrus that is correlated with increased reporting of nausea 
scores in 17 nausea susceptible subjects during the nausea video. 
 
Figure 35. Time course Of Brain Activity (Raw diagram of minute by minute average 
brain activity in the inferior frontal gyrus in 17 nausea susceptible subjects that 
progressively increases while watching the motion video for 10 minutes reaching a peak 
in the last third of the video that corresponds with the nausea scores reported by the 
nausea susceptible subjects. In contrast, there is no specific trend seen during the 
control video). 
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4 DISCUSSION 
4.1 Adaptation of a novel visually induced motion sickness 
nausea model to study the brain processing of nausea 
Nausea and anxiety levels was higher in the susceptible compared to resistant subjects 
with the ICC of moderate to good reproducibility between chapter 3 and chapter 4 
studies although less with the MRI goggles video compared to the projected video in 
Chapter 3 possibly due to a larger field of view in the projected video (Bos et al., 2010). 
As these subjects have had their subjective reports of nausea validated by objective 
cardiac sympathetic arousal, parasympathetic withdrawal, shift of normal to dysrhythmic 
gastric myoelectrical activity, increased cortisol and increase state anxiety (refer 
Chapter 3), we are making the assumption that they are experiencing the same 
psychophysiological changes as described in chapter 3 and thus similar brain activity 
was likely when they were reporting nausea inside the MRI scanner.  
All 28 subjects increased activity in the middle temporal gyrus and occipital lobe; and 
decreased activity in cerebellum and parahippocampal gyrus while watching the motion 
video compared to control. As previously demonstrated the increased activity in the 
occipital lobe (Brandt et al., 1998) (Napadow et al., 2012a) and the middle temporal 
gyrus (Napadow et al., 2012a) is likely due to the effect of the motion video on the visual 
cortices  compared to the control. 
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Of possibly greater importance, decreased cerebellar and parahippocampal activity may 
be associated with the sensory mismatch interactions proposed to be the mechanism 
behind the development of vection and eventually motion sickness. It is likely that the 
conflict in the visual stimuli informing the brain that the subject is in motion with the 
information from the vestibular system suggesting that the subject is stationary led to 
the vestibular system being inhibited (Brandt et al., 1998). The reverse has also been 
shown to be true with vestibular system activations inhibiting the parieto-occipital visual 
pathways in fMRI studies using a mild vection stimulus without achieving nausea 
(Brandt et al., 1998, Brandt et al., 2002, Wenzel et al., 1996).  
I have demonstrated that the virtual reality stimulus can be adapted to the fMRI 
investigative environment with the pre-existing infrastructure and not needing 
complicated or expensive modifications to the MRI infrastructure (Napadow et al., 
2012a, Kowalski et al., 2006). To our knowledge, this is the first easily adaptable virtual 
reality stimulus based on real world scenery that has been successfully utilised for the 
fMRI study of nausea specifically. 
 
4.2 Brain processing of visual motion induced nausea 
When comparing the nausea susceptible versus resistant subjects during the motion 
video there was increased substantia nigra activity in susceptibles. As substantia nigra 
is part of the basal ganglia pathway that is involved in maintaining posture (Henderson 
et al., 2005, Su et al., 2002), its activation may be due to increased motion related brain 
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processing in the susceptible individuals that are experiencing significant motion effects 
from the stimulus. Substantia nigra is involved in motor control (Hodge and Butcher, 
1980) and typical postural responses to motion stimuli which are altered when 
experiencing motion sickness (Shepard et al., 1990). 
 
Further analysis in the nausea susceptible subjects revealed that increasing inferior 
frontal gyrus activation was positively correlated with increasing levels of nausea 
reported. This is consistent with an earlier preliminary study (Miller et al., 1996) using 
Magnetic Source Imaging with head yaw-axis rotation and ingested syrup of ipecac as 
the stimuli to induce nausea that was reversed with a 5-hydroxytryptamine3 receptor 
antagonist. This was also supported by a recent study showing bilateral prefrontal 
cortical activation with simulated optokinetic drum inducing nausea (Napadow et al., 
2012b). The same area was also activated by galvanic and caloric vestibular stimulation 
evoking feelings of motion or nystagmus but not up to the point of nausea in fMRI 
(Bense et al., 2001, Fasold et al., 2002). Furthermore, it was observed in  PET studies 
in migraine patients that onset of headaches associated with nausea activated the 
inferior frontal gyrus (Denuelle et al., 2007). Taking these results together the inferior 
frontal gyrus is either involved in (conscious) perception of discordant information of 
body motion or of nausea, with the latter hypothesis supported by the (Miller et al., 
1996) report of activation by a nauseogenic stimulus i.e ingested ipecac which likely 
acted via abdominal visceral afferent pathways.  
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Other than regions of the brain that was activated in these studies, there were 
consistent inhibitions seen in all the aforementioned analysis in the parahippocampus. 
When comparing between the motion versus control video for all subjects the 
parahippocampus was inhibited during motion video. Furthermore, the 
parahippocampus activity was also decreased when comparing nausea susceptible and 
resistant subjects during the motion video. On top of that, parahippocampus activity 
decreased as nausea levels increased in susceptible subjects. Conversely, the 
parahippocampus was activated in resistant subjects as a group during the motion 
video (right parahippocampus, cluster size 798, peak talairach coordinates (x=25.28, 
y=-18.52, z=-9.90), p<0.0002). 
It is possible to speculate that the parahippocampus is a pivotal area involved in the 
processing of the visual motion induced nausea in our subjects such that its inhibitions 
signifies the disorientation induced by the stimulus leading to the sensory conflict 
(Reason and Brand, 1975) postulated to generate nausea. Interestingly the nausea 
resistant individuals as a group increased left parahippocampal activity that may confer 
some protection against disorientation that may be involved in the generation of nausea. 
It was postulated before that motion sickness develops specifically when postural 
control is threatened by misinterpretation of the environment (Riccio and Stoffregen, 
1991), consistent with the evidence that spatial orientation loss inevitably produces loss 
of balance in addition to provoking nausea (Takahashi et al., 1995). Behavioural studies 
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have demonstrated that human infants spatially disorientated by being spun around with 
their eyes closed and left facing a random wall in a room (Hermer and Spelke, 1994, 
Hermer and Spelke, 1996) re-orientate themselves solely on the basis of the geometry 
of the local visual scenery like the horizon or the corner of a room. The same was seen 
with rats during spatial disorientation also (Cheng, 1986, Margules and Gallistel, 1988). 
It is proposed that this is evidence for a phylogenetically and developmentally primitive 
component involved in spatial orientation. In addition, clinical lesions in humans (Habib 
and Sirigu, 1987, Hublet and Demeurisse, 1992) in the parahippocampus presents with 
spatial disorientation to their surroundings with reports of a patient who selectively lost 
the ability to orient himself in the environment after a stroke involving the right 
parahippocampal gyrus (Luzzi et al., 2000). As disorientation is common with vection 
caused by visual motion induced nausea (Kennedy et al., 2010), it is likely that the 
parahippocampus plays an important role.  
Observations from fMRI human studies using topographic recall and learning of a virtual 
maze revealed that the parahippocampus plays a pivotal role in spatial awareness and 
navigation especially in studies using cityscapes like the ones used in this study’s 
motion video stimulus (Aguirre et al., 1996, Epstein and Kanwisher, 1998, Ishai et al., 
1999).  
In this study, the hippocampus (left hippocampus, cluster size 3484, peak talairach 
coordinates (x=-28.89, y=-18.52, z=-9.90), p<0.0012) was also inhibited in all subjects 
during the motion video. There is a clinical case of a young woman with chronic 
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topographical disorientation after a haemorrhagic lesion of the right temporo-occipital 
region involving the hippocampus (Rusconi et al., 2008). Primates research in aged 
female rhesus macaques revealed the hippocampal M1 muscarinic receptor function 
was associated with spatial learning and memory (Haley et al., 2011). Older studies 
showed the rat hippocampus has neurons with receptive fields for current position in the 
environment (spatial awareness), with lesions there disrupting place learning suggested 
that the hippocampus is involved in processing large-scale environmental space 
(O'Keefe and Dostrovsky, 1971). However, further research showed that the rat 
hippocampus plays an important role in spatial representation and learning with lesions 
there leading to disorientation (Morris et al., 1982).  Thus the inhibition of the 
hippocampus in all our subjects during the motion video that is not seen during the 
control video might be related to some form of disordered processing of the visual 
stimuli as part of the sensory conflict theory hypothesised to play a role in the 
generation of nausea (Reason and Brand, 1975). 
Thus evidence from both human and animal studies suggests that the 
parahippocampus and the hippocampus respectively are critical for orientation and 
navigation; and clinical lesions of the hippocampus and parahippocampus present with 
disorientation. Visual motion induced nausea possibly starts from vection generating 
disorientation that develops into nausea and both worsen progressively with increasing 
exposure to the stimulus. This may possibly be the first objective evidence of the 
pathway involved in the universally acknowledged and accepted sensory conflict theory 
initially proposed by (Reason and Brand, 1975). What is equally as important if not more 
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is the fact that the parahippocampus appears to have a protective role against the 
development of visual motion induced nausea. This now needs specific studies 
targeting the limbic structures  
 
 
 	  
 149 
 
4.3 Limitations and future studies 
More detailed investigation using non-visual/vestibular stimuli to evoke nausea will be 
needed to determine if the brain processing of nausea is similar with different input 
pathways or if there are important differences that may potentially be important when 
thinking about treating the widely varying causes of nausea for the clinician. 
Investigating disease states associated with nausea may be a potential option such as 
cyclic vomiting syndrome (Olden and Chepyala, 2008) and migraine (Cuomo-Granston 
and Drummond, 2010). 
 
In this study, areas of the brainstem like the brainstem nuclei or the NTS that are 
postulated to play a key role in nausea pathways were not seen, however these 
medullary nuclei are at the limit of fMRI spatial resolution and are also susceptible to 
cardiorespiratory artefacts. In future fMRI studies specifically targeting the brainstem 
using 3 Tesla MRIs for better spatial resolution or possibly complementary studies like 
high resolution research tomography (HRRT) that was recently shown to be able to 
quantify the serotonin transporter availability in the brainstem may be helpful in 
developing a better understanding of brain stem processing of nausea (Schain et al., 
2012). 
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This stimulus evoked specific/characteristic pattern of changes in brain activity that will 
now permit studies of pharmacological interventions aimed at normalising these 
changes with the intention of treating nausea. It is hoped that with the identification of 
the possible brain pathways involved in processing nausea that the pharmacological 
studies will be able to be further refined. 
 
It would now be useful to know if the nausea brain response stimulated by the motion 
video can be modulated by drugs treating motion sickness (Miller et al., 1996) to ensure 
the areas of the brain highlighted above are reversed (suggesting that it plays a key role 
in nausea processing) when individuals are able reduce their nauseous response to the 
same stimulus.  
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1 Introduction 
The prefrontal and limbic cortexes as well as the substantia nigra appear to play a role 
in nausea generation in nausea susceptible individuals. It would now be useful to know 
if these brain regions are specific for nausea with pharmacological studies. There are 
many on-going debates for the best treatment of nausea and vomiting depending on its 
cause and the jury is still out (Green et al., 2012, Davis and Hallerberg, 2010). From the 
available literature scopolamine appears to be the first line recommendation for its 
efficacy and low incidence of side effects in comparison with other agents (Spinks et al., 
2004).  
Hyoscine bromide is an antimuscarinic compound and a derivative of scopolamine. It 
has a diverse role in medicine, such as the prevention of motion sickness, pelvic 
magnetic resonance imaging (MRI) by suppression of intestinal and uterine smooth 
muscle contractions (Fujimoto et al., 2010, Dosda et al., 2003, Winkler and Hricak, 
1986, Nakai et al., 2008).  Hyoscine has high affinity for muscarinic receptors (Elrod and 
Buccafusco, 1988) [little selectivity for receptor subtypes M1–M5; (Renner et al., 2005)] 
and  competitively antagonizes acetylcholine on postsynaptic muscarinic receptor sites 
(Deutsch, 1971). Scopolamine has negligible affinity for histaminergic and dopaminergic 
receptors (Peroutka and Snyder, 1982). The central nervous system (CNS) effects 
consist of drowsiness, reduced attention and memory impairment, and a range of other 
CNS effects including changes in several EEG frequency bands (Ebert et al., 2001, 
Ebert and Kirch, 1998, Ebert et al., 1998). The peripheral effects of scopolamine include 
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typical antimuscarinic effects like a dry mouth, skin and throat, decreased blood 
pressure, decreased heart rate, difficulty urinating, constipation, pupil dilatation and 
impaired eye focusing (mydriasis and cycloplegia).  
It is interesting to note that muscarinic acetylcholine receptors were shown to be 
present in high concentrations in the prefrontal cortex and the hippocampus 
(Nathanson, 2008) and to have a role in spatial learning and memory in rodents, 
nonhuman primates, and humans (Wisman et al., 2008, Gage et al., 1988, Fredrickson 
et al., 2008, Thomas et al., 2008). Scopolamine impairs cognitive task performance in 
rats (Biggan et al., 1996), dogs (Araujo et al., 2005), rhesus monkeys (Savage et al., 
1996, Taffe et al., 1999), and humans (Rosier et al., 1998) and possibly reducing the 
conscious sensation of nausea. The regions critical for cognitive function like the 
prefrontal cortices and the hippocampus express type 1 (M1) subtype muscarinic 
receptors mostly (Gage et al., 1988, Fredrickson et al., 2008, Thomas et al., 2008, 
Flynn et al., 1995a, Flynn et al., 1995b, Tamminga, 2006, Wisman et al., 2008) and the 
muscarinic type 2 (M2) after (Jagoda et al., 2003, Rouse et al., 2000). The M2 may also 
contribute to cognitive function (Gautam et al., 2006). With the brain regions of interest 
that were discovered in chapter 4 known to have expressions of M1 and M2 muscarinic 
receptors, scopolamine is a likely candidate to reverse the prefrontal and limbic cortical 
activation due to visual motion induced nausea. 
There hasn’t been any study designed specifically to look at the effects of scopolamine 
modulation on the fMRI brain activity with nausea to my knowledge. Thus what we know 
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regarding scopolamine’s effects on the brain are mostly from previous studies using 
scopolamine as a pharmacological model substance based on the “cholinergic 
hypothesis” of memory loss in senile dementia of the Alzheimer type. In the human 
brain by fMRI, it has been found to modulate the hippocampus/parahippocampal gyrus 
and disrupt spatial memory (Antonova et al., 2011b).   
 
1.1 Hypothesis 
Therefore my hypothesis was that the prefrontal and limbic involved in the genesis of 
visual motion induced nausea would be reversed by scopolamine intervention.  
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2 Method 
2.1 Study design and setting 
This was a crossover study i.e. the same subject is exposed to both scopolamine and 
placebo administration during motion video. It was carried out at the Institute of 
Psychiatry, King’s College London (KCL). 
	  
2.2 Ethical approval 
The NRES Committee South Central - Portsmouth (12/SC/0117) approved these 
studies. 
 
2.3 Subjects 
Sixteen (8 males, 8 females) healthy right handed nausea susceptible volunteers 
median age 24 years, range 19 - 36 years were recruited with 5 subjects who had 
participated in studies described in Chapters 3 and 4. Subjects were preselected based 
upon moderate to severe nauseous response to previous exposure of the stimulus. All 
subjects gave written informed consent. Volunteers were recruited to meet the following 
criteria: (i) normal body mass index, (ii) no abnormality on clinical examination, including 
a history or presence of cardiac, ophthalmologic, gastro-intestinal, hepatic, or renal 
disease, or other condition known to alter their response to visually induced motion 
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sickness nausea e.g. vestibular disease, (iii) no abnormality on electrocardiogram 
examination at screening (iv) no abuse of alcohol (defined as an average intake >21 
units per week or 3 units per day); and (v) no history or presence of neurological or 
psychiatric conditions (e.g. stroke, traumatic brain injury, epilepsy, space-occupying 
lesions, multiple sclerosis, Parkinson’s disease, vascular dementia, transient ischaemic 
attack, schizophrenia, major depression, etc). Subjects with any of the following were 
excluded: (i) received prescribed medication within 14 days prior to the first visit, which 
might interfere with the study procedures or compromise safety, (ii) received over-the-
counter medicine within 48h of the study, (iii) participated in a trial with any drug within 3 
months before the first visit, (iv) had a caffeinated drink within 24 h of visit. 
 
2.4 Materials and Protocol 
Subjects arrived 60 minutes before their experiment to allow for the accurate timing of 
the administration of the drug or placebo capsule 30 minutes before the experiment. 
Before the administration of the capsule, subjects heart rate were assessed as well as 
the ‘n-back’ task and questionnaires monitoring motion sickness symptoms and anxiety 
state that were repeated at the end of the experiment. Heart rate was also assessed 
before the capsule was given and at the end of the experiment 2 hours later. After 
similar preparation as the protocol for Chapter 4, the subject was brought into the MRI 
room. Subjects were provided with a pair of goggles that displayed the stimulus and 
questionnaires in front of the subject’s eyes. An emergency buzzer was also put into 
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their left hand to allow the subjects to end the experiment at any point in time if they 
become too uncomfortable due to the video or drug side effects. Close monitoring of 
their vital signs with pulse oximetry, skin conductance response (SCR) and respiratory 
belt was started once they are inside the scanner room with microphones picking up 
their voices as well as a video overseeing the subject in the scanner in the monitoring 
panel for safety reasons. After starting the stimulus, minute-to-minute nausea reporting 
using a visual analogue scale was collected during the fMRI scans using a button box 
on their right hand.  
  
 
Figure 36. Schematic summary of the experimental protocol: After 6 hours of fasting 
subjects arrived for either drug or placebo administration and questionnaires which e.g. 
assess motion sickness symptoms and anxiety, reassessed just before starting the 
video after which minute to minute nausea reporting was determined and another 
MSAQ and STAI-S questionnaire done at the end of the video. This is essentially similar 
with chapter 4 protocol with the exception that drug or placebo was administered. 
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2.5 Distraction task (n-back) 
As scopolamine causes significant drowsiness as a side effect (Spinks et al., 2004), a 
distraction task (letter version of n-back; (Ragland et al., 2002)) was used to assess 
subjects level of attention.  The n-back has been used for experimental research in 
working memory [reviewed by (Jaeggi et al., 2010)]. A sequential presentation of letters 
putting a constant demand on attentional resources by requiring constant update and 
retrieval of information was administered to the subjects with three levels of difficulty: 1-
back condition requires a response to any letter identical to the one before (i.e. one 
letter back); 2 and 3-back needs a response to any letter that is identical to the letter 
presented 2 or 3 letters back respectively (see  
Figure 37). The response required is pressing a button connected to a PC that stores 
the response times and accuracy for post-hoc analysis. 
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Figure 37: Pictorial representation of 1,2 and 3-back of the n-back tasks. Subjects are 
presented a sequence of letters and respond by pressing a button when they see a 
letter identical to 1, 2 or 3 letters before it respectively. (Adapted from (Coen et al., 
2007). 
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2.6 Baseline activity 
Subjects were encouraged to relax and focus on a target presented in the goggles for 
two and a half minutes before the video is started. This forms the baseline recordings. 
 
2.7 Assessment of motion sickness susceptibility and anxiety 
levels 
Subjects used a button box (four button box with first button for none and then mild, 
moderate and last button for severe) on their right hands to self-report nausea and 
anxiety scores before and at the end of each video as well as nausea scores every 
minute during the video. The ratings were reported using the same visual analogue 
scale used during study 1 explained above. Both MSAQ and STAI-S questionnaires 
were also administered just before and at the end of the videos. A two-way, random 
effects, average measures intra-class correlation (ICC) model for continuous variables 
were calculated between the chapter 3 and 4 visits for the 28 subjects (Green et al., 
2012) to assess reproducibility of their nausea induction. Please refer Chapter 2 section 
2.4.6 for more details. 
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2.8 Exposure to motion video stimulus 
Subjects watched the motion video through a pair of goggles as in chapter 4 section 
2.7. The goggles are positioned with rubber eyepieces to cover their eyes to limit their 
field of view to only the screen and delivered the stimulus using two LCD screens in 
front of each eye to create an illusion of a large screen in front of them. 
 
2.9 Hyoscine hydrobromide administration for the prevention of 
motion sickness 
The prevention and control of motion sickness symptoms includes pharmacological 
interventions, behavioural therapy and complementary medicine with varying success. 
This initial study of the pharmacological modulation of nausea pathways in the brain 
was approached with the safety and comfort of the subjects first and foremost as they 
are healthy human volunteers. Hyoscine bromide was chosen as it is licensed and 
widely used for oral prophylaxis of motion sickness and has low incidences of side 
effects compared with other agents with the pharmacokinetics and pharmacodynamics 
of scopolamine known and is currently the first line recommendation (Spinks et al., 
2004). Thus Kwells Hyoscine Hydrobromide 300 microgram orally was administered 30 
minutes before the start of the experiment (Liem-Moolenaar et al., 2011) in one visit with 
another visit a placebo was given in a double-blinded manner. Both were manufactured 
and the order of the drug and placebo randomised by the Royal Victoria Infirmary, 
Newcastle upon Tyne Hospitals NHS Foundation Trust. 
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2.10 Subjective monitoring 
A visual-analogue-scale symptoms (VAS) questionnaire and motion sickness 
assessment questionnaire (MSAQ) described in chapter 2 section 2.4.7 documented 
any symptoms reported by the subjects. A visual scale from 1 to 4 was used with 1 
being, without symptom, and 2 being mild symptom, 3 being moderate symptoms and 4 
being maximum level of tolerated symptom. State anxiety status was assessed using 
the state version of the STAI. 
 
2.11 Objective monitoring 
The SCR was recorded on the subject’s left hand continuously throughout the 
experiment. Cardiac pulse and respiratory effort data were monitored using a pulse 
oximeter (InVivo) and a respiratory effort transducer (BIOPAC), respectively. The pulse 
oximeter was placed on the subject’s left index finger. The respiratory effort belt was 
placed around the subject’s abdomen. The vital signs monitoring was performed similar 
to those described in chapter 2. Video was delivered through fMRI compatible goggles 
with an eye-tracker video to monitor subject’s attention to the stimulus and pupil location 
(NordicNeuroLab GmbH VisualSystem, Norway). 
The fMRI data (T2*-weighted images) was collected on a General Electric Signa Excite 
II 1.5 T HD scanner based at the Centre for Neuroimaging Sciences, Institute of 
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Psychiatry, King’s College London. Head movement was restricted using foam padding 
within the head coil and an eye movement’s tracker was mounted onto the head coil 
together with the in-built MRI compatible goggles delivering the stimulus. Prior to the 
start of the fMRI experiment, a high-resolution gradient echo structural scan (43x3mm 
slices, 0.3 interslice gap, TE 40ms, TR 3000ms, flip angle 90˚, matrix 128², in plane 
voxel dimensions 1.875x1.875) was acquired in each volunteer to be used for Talairach 
normalisation. During fMRI, a total of 300 T2* weighted images per slice (40x3mm 
slices, 0.3 interslice gap, TE 25ms, TR 3500ms, flip angle 90˚, matrix 64²), depicting 
blood oxygen level dependant (BOLD) contrast were collected as subjects viewed the 
control and motion video.   
 
2.14 Statistical analysis  
XBAM version 4.1 (http://brainmap.co.uk/ referenced on the 8th of August 2012), a 
package developed at the Institute of Psychiatry, King’s College London, was used to 
analyse fMRI data. It implements permutation-based nonparametric methods to 
minimise the number of assumptions used in making statistical inference (Brammer et 
al., 1997). After acquisition, fMRI data pre-processing, smoothing and individual brain 
activation mapping was performed (Coen et al., 2009). Analysis of covariance was 
performed on the effect size maps in Talairach and Tournoux’s standard space 
(Talairach and Tournoux, 1988) with each voxel statistic corrected for the actual number 
of participants contributing to the calculation (Thirion et al., 2007). An analysis of 
covariance (ANCOVA) examining the main effect of several different groups on whole-
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brain neural activity was done and a clusterwise p value of 0.01 (corrected for whole 
brain volume using permutation testing). Correlation analysis for brain activity to the 
level of nausea reported were analysed during the nausea video. Comparisons were 
also made between activity in the whole brain for all subjects between placebo versus 
scopolamine and during the motion video.  
Psychometric, nausea questionnaires, and autonomic data were analysed using 
matched-pair t-tests and Wilcoxon tests to compare the means and medians. Pearson’s 
and Spearman’s correlations were used to determine the relationship between 
measurements. Independent-measures t-tests and Mann-Whitney tests were used to 
compare groups. Reproducibility of the studies used intra-class correlation comparison 
(ICC) and agreement was measured using two-way mixed average measure ICC model 
for continuous variables. Confidence intervals for the ICC were calculated according to 
the methods of Scheffe (Green et al., 2012). ICC were interpreted according to 
suggestions made by Yen et al (2002) as: - excellent (0.75-1), moderate (0.4-0.74) or 
poor (0-0.39) (Davis and Hallerberg, 2010). Commercially available statistics packages 
(SPSS, Chicago, IL, USA and GraphPad, San Diego, CA, USA) were used for the 
analysis. P values <0.05 were considered to be of statistical significance. 
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3 RESULTS 
3.1 Response to videos during the fMRI study 
All 16 subjects completed and tolerated the studies well. There was significantly more 
nausea after the video during the placebo visits. There were no other significant 
changes. The overall results are summarised in Table 16. 
 
Five of the subjects responded to treatment with scopolamine (5 scopolamine 
modulated) and had less nausea during the motion video compared to after placebo. 
There was also a slight but not statistically significant lower heart rate and a 
deterioration of the 1-back task performed with higher response time (ms) and lower 
accuracy (% correct). 
 
Six of the subjects appear to have developed more nausea during the drug visit 
compared to placebo visit. Meanwhile, 5 of the subjects did not have any response to 
the motion video. There was also a slight but not statistically significant lower heart rate 
and a deterioration of the 1-back task performed with higher response time (ms) and 
lower accuracy (% correct).  
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Variable Baseline Median Placebo Hyoscine 
Baseline 
vs. 
Placebo 
Baseline 
vs. 
Hyoscine 
Placebo vs. 
Hyoscine 
Nausea scores 
(VAS) 1.21 1.93 1.35 p<0.05 p=0.35 p=0.16 
Anxiety scores 
(STAI) 25.00 30.00 28.00 p=0.09 p=0.29 p=0.57 
HR (bpm) 68.32 67.11 67.93 p=0.13 p=0.36 p=0.72 
1-back response 
time (ms) 535.98 554.18 562.37 p=0.25 p=0.16 p=0.62 
1-back accuracy 
(%) 93.28 92.21 91.89 p=0.19 p=0.08 p=0.33 
Table 16 Medians of baseline, placebo and hyoscine visits and the statistical 
comparisons between them (Wilcoxon test). 
 
 
3.2 Brain activity in placebo versus scopolamine for all subjects 
All subjects demonstrated an increase in activity in the left occipital lobe and lingual 
gyrus after placebo compared to scopolamine (Table 17).  
Cerebral Region 3D Cluster size Peak Talairach Coordinates (x, y, z) Probability 
Left Occipital 
Lingual 192 -14.44 -77.78  -6.60 0.0007 
Table 17. Brain Activity in Placebo versus Scopolamine during Motion Video for All 
Subjects There was increased activity in these brain areas during motion video after 
placebo versus scopolamine in all 16 subjects. 
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3.3 Brain activity in placebo versus scopolamine for the five 
scopolamine modulated subjects 
All subjects demonstrated an increase in activity in the left occipital lobe, cuneus (Table 
19); and a decrease in activity in the left occipital lobe, middle occipital gyrus while 
watching the motion video (Table 19)  
Cerebral Region 3D Cluster size Peak Talairach Coordinates (x, y, z) Probability 
Left Occipital 
Cuneus 41 -10.83 -81.48   3.30 0.0035 
Table 18. Brain Activity for Scopolamine Modulated Subjects during the Motion Video in 
Placebo versus Scopolamine Administration. There was increased activity in these brain 
areas during motion video after placebo versus scopolamine in all 5 subjects. 
 
 
Cerebral Region 3D Cluster size Peak Talairach Coordinates (x, y, z) Probability 
Left Middle 
Occipital Gyrus 85 -43.33 -85.19   9.90 0.0022 
Table 19. Brain Activity for Scopolamine Modulated Subjects during the Motion Video in 
Placebo versus Scopolamine Administration. There was decreased activity in these 
brain areas during motion video after placebo versus scopolamine in all 5 subjects. 
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4 DISCUSSION 
4.1 Varying responses from 16 healthy volunteers to 
scopolamine 
Five of the sixteen subjects responded to treatment with scopolamine (5 scopolamine 
modulated) and had less nausea during the motion video compared to after placebo. 
The rest of the subjects did not. This is consistent with the variable scopolamine 
efficacy. For instance (Spinks et al., 2004) showed meta-analysis of transdermal 
scopolamine studies having a relative risk to develop nausea of 0.48 (95% confidence 
interval (CI) 0.32 to 0.73) however oral scopolamine studies were not meta-analysed 
due to too widely varying differences between studies (e.g. different sample sizes, 
different dose of oral scopolamine).  
Six subjects developed more nausea during the drug visit compared to placebo visit that 
may be due to factors like scanner anxiety (2 subjects reported scanner anxiety during 
their drug visit and that may be potentially avoided in the future with an additional mock 
scan (Lueken et al., 2012). Another 2 subjects had excessive drowsiness due to lack of 
sleep night before. One of the subjects scored the Weinberger test as possibly lying and 
thus it would be best to exclude that person. A possible explanation is that these 
subjects were not sensitive to scopolamine as all subjects did not report any classical 
scopolamine side effects e.g. dry mouth, increase in heart rate after drug, or 
deterioration in n-Back task and this is consistent with previous studies (Spinks et al., 
2004). In terms of adequate dosing of scopolamine, previous studies have shown with 
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doses of 300 and 600 micrograms that both doses were adequate for prevention of 
motion sickness with more side effects seen in 600 and increasing side effects noted at 
900 micrograms (Renner et al., 2005, Ebert et al., 2000). Thus the recommended 300 
microgram was aimed for with the stimulus given when scopolamine should peak about 
an hour after dose (ibid). The dose chosen was both for safety as well as to prevent 
confounding factors of side effects and subject discomfort and yet have adequate 
treatment.  
Meanwhile, 5 of the subjects had mostly mild and up to moderate response to the 
motion video. This may be due to habituation as they were involved in the previous 
studies as well (Dai et al., 2011, Bos et al., 2010). All possible precaution was taken to 
prevent this with the initial visits taking place 6 months before the 1st MRI visits and then 
in between visits another week. Unfortunately in this case all the subjects who had been 
exposed to the stimulus before appear to have habituated to the stimulus in the MRI 
even though they still reported moderate to severe nausea during the screening study 2 
weeks before the MRI visit with the video projected upon a large screen.  
This was a pilot study and the results herein discussed must be viewed with the 
knowledge that when analysing all the subjects together they are a heterogenous group 
and also it is likely to be underpowered when looking at the scopolamine-modulated 
subjects’ sample size of five. But this is the first visually induced motion sickness 
nausea study with scopolamine designed specifically to modulate the cortical pathways 
involved in the brain processing of visual motion induced nausea and it may provide us 
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with a preliminary glimpse into looking at the nausea pathways modulated by 
scopolamine. 
 
4.2 Developing a safe and reliable stimulus for studying nausea  
All the subjects completed all studies and did not have any retching or vomiting. 
Furthermore, none of the subjects reported any side effects after scopolamine and thus 
we have likely erred on the side of caution here. Thus it was a safe study. 
However, there was no clear scopolamine modulation of the stimulus due to the wide 
individual variations to scopolamine response. It is possible that an additional visit to 
determine if these volunteers can show scopolamine modulation of their responses to 
the video might have proved useful. 
Nausea was still induced in 69% of the subjects however subjects reported poor ICC to 
nausea and anxiety scores (intra-class correlation coefficiency of 0.23). This is likely 
due to the smaller field of view (Bos et al., 2010) and the possibility of reduced 
anticipation of nausea as they are being told they might or might not get a drug to 
reduce their nausea before the study (Morrow et al., 2002b).  
In terms of the fMRI data, when comparing the scopolamine versus placebo in all 16 
subjects there was decreased occipital lingual activity with no regions of significantly 
increased activity. However when only the 5 scopolamine modulated subjects were 
analysed together comparing scopolamine versus placebo, there was significant 
increase in the occipital cuneus and a decrease in the middle occipital gyrus activity. 
 171 
 
These visual pathway regions are likely involved in processing the visual stimuli. This is 
consistent with previous studies of apparent self-motion using translating (Napadow et 
al., 2012b, Brandt et al., 1998) and stationary (Riedel et al., 2005) visual stimuli 
suggesting that vection is mediated by medial temporal gyrus and parieto-occipital 
areas that are part of the visual pathway.  
 
Future studies will need to preselect subjects who are susceptible to the nausea 
stimulus and then study if these subjects are scopolamine sensitive before proceeding 
to the fMRI study. 
 
4.3 Prefrontal cortices modulation by scopolamine 
Chapter 4 studies showed that the inferior frontal gyrus was positively correlated with 
increasing nausea. The same correlation was not seen and neither was there a 
negative correlation after placebo for all subjects. Thus the chapter 5 subjects may not 
be comparable with the previous study, as the same activation was not seen during 
placebo visit. The placebo visit in chapter 5 should arguably be similar to the motion 
video stimulation in chapter 4 studies except that their anticipation may be altered due 
to taking the drug or placebo. Thus it was to no surprise that there were no significant 
correlations seen for all subjects during the scopolamine visit. 
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When looking at the single group level activity, all subjects after placebo showed 
significant prefrontal cortex activation in the superior frontal gyrus. This is consistent 
with the chapter 4 findings of increased prefrontal cortex activity with motion video. 
When all the subjects were investigated after scopolamine, this activation had been 
reversed with significant inhibition of bilateral inferior frontal gyri and left middle frontal 
gyrus. Thus, although the between groups of placebo versus scopolamine comparisons 
did not show a significant relationship, the more basic group level activations may 
possibly be moving along the right direction as was expected. This is taken with the 
naïve and likely wrong assumption that the prefrontal cortices can be grouped together.  
Further analysis however did show possible supporting evidence for the inferior frontal 
gyrus in the genesis of nausea. After scopolamine administration all the subjects as a 
group had significantly reduced bilateral inferior frontal gyrus activity. When placebo 
was compared with scopolamine brain activity, there was also a trend towards the 
bilateral inferior frontal gyrus becoming less active (post-hoc reanalysis of 5 subjects 
modulated by scopolamine with inferior frontal gyrus significantly inhibited bilaterally 
after lowering Bonferonni correction with cluster p value at p=0.05; Left and right cluster 
size 43 & 37; peak talairach coordinates x,y,z are -36.11, 25.93, -9.90 & 25.28, 14.81, -
9.90; p<0.02 & p<0.03). 
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4.3 Limbic cortex 
It was also observed in the chapter 4 studies that the limbic parahippocampus and 
hippocampus was inhibited with increasing nausea. The same correlation was not seen 
and neither was there a positive correlation after placebo for all subjects. And again 
there were no significant correlations seen for all subjects during the scopolamine visit. 
There were also no significant changes when comparing placebo versus scopolamine. 
It was also only with further post-hoc analysis that we were able to observe that there 
was a trend of increased left parahippocampus activity after scopolamine administration 
versus placebo in the 5 scopolamine modulated subjects with a trend of decreased right 
parahippocampus activity. 
4.4 Limitation and future studies 
It is a limitation of this study that the mild to moderate visual motion induced nausea 
stimulus was habituated to by about a third of our subjects. And it is also arguable that 
the mild to moderate nausea induced in these subjects may not have been strong 
enough to show a reversal with an intervention. Thus it is possibly necessary at this 
juncture to discuss what are the other options for a nausea stimulus we may consider 
as the other stimuli may also be considered for future studies in fMRI to ascertain if the 
visual motion induced nausea pathway is generalizable to other pathway(s) of nausea.  
Ideally a stimulus induces nausea alone is used to investigate the central nervous 
system pathways of nausea.  
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When considering an ingested or an injected agent, its appropriate dose selection is 
critical. This relies on the availability of detailed dose-response information in humans. 
A fast acting agent like apomorphine where onset of nausea and vomiting may be within 
minutes it may be difficult to separate the pathways involved in the two events. Other 
alternatives include ingested agents like syrup of ipecac (Minton et al., 1993), (-) 
tryptophan (Greenwood et al., 1975), L-DOPA (Davis et al., 1986), and the partial 5-
HT1A receptor agonist buspirone, that potentiates morphine induced nausea  (Oertel et 
al., 2007).  
Another possibility would be avoiding the agonist drugs and consider antagonists. They 
may need concurrent administration of an emetic stimulus since some work by reducing 
the threshold for vomiting although some can induce nausea when given alone. An 
example would be the opioid antagonist naloxone (Kobrinsky et al., 1988) and the CB1 
receptor antagonist Rimonabant (Pi-Sunyer et al., 2006) that induce nausea as a dose-
related side effect. 
A major factor to consider is the risk of vomiting. There is a real danger of aspiration if 
the subject is supine in a scanner with head restrains as it may not be possible to 
remove the subject rapidly other than vomiting being a potentially confounding factor 
(Ladabaum et al., 2001). The scanner may also be contaminated by aerosolized vomit 
containing infectious agents. These issues may be resolved by technical developments 
in scanner design with vertical more open designs however there is no known timeline 
when they may come out of development.  
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Alternatively a well studied, easily controlled, discrete experimental stimulus for the 
induction of nausea and its associated gastrointestinal motor changes would be caloric 
or galvanic vestibular stimulation (Brandt and Strupp, 2005, Wolf, 1965). It would still be 
necessary to compare these results with other stimuli activating the area postrema 
and/or the abdominal vagal afferents. 
Last but not least, there is evidence that a number of observations in crude early 
electrical stimulation studies may be worth pursuing with more sophisticated techniques 
presently available. Brief looks at these studies that must be interpreted with caution, 
are for example stimulation of the extreme lateral portion of the primary somatosensory 
cortex (S1) provokes nausea and a sick-feeling (Penfield and Rasmussen, 1950). 
Meanwhile, anterior cingulate cortex stimulation induced nausea, vomiting, and 
epigastric awareness (Devinsky et al., 1995). In addition, stimulation of the frontal lobe 
in either cerebral hemisphere (Sem-Jacobsen, 1968) evoked “Nausea I” — where the 
subject reported nausea that was followed by sudden vomiting and immediate recovery; 
and “Nausea II” — where the subject reported more intense nausea with perspiration 
and increased breathing rate and depth. Thus, more developed techniques such as 
deep brain stimulation or the non-invasive transcranial electromagnetic stimulation 
could potentially confirm the involvement in nausea of sites identified by imaging 
studies. 
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As discussed above, although other modalities of studying nausea are available, each 
of them have their own difficulties none currently are able to produce a state of 
sustained nausea with a minimal risk of vomiting. 
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CHAPTER 6 
CONCLUDING	  DISCUSSION	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1 The human model of nausea 
There is a need for using functional brain imaging in humans to obtain an insight into 
brain processing of nausea. This understanding will in future help to develop 
quantitative means for assessing anti-emetic efficacy. With few functional brain imaging 
studies focused on nausea genesis, our knowledge is mainly based on animal studies 
that come primarily from the rat (lacking an ability to vomit), cat, dog, ferret and 
nonhuman primates but there are substantial differences in cerebral cortical anatomy 
between species e.g. the primates, cetaceans, and other mammals (Craig, 2009b, 
Craig, 2009a, Craig, 2002, Dunbar and Shultz, 2007, Marino, 2007, Butler et al., 1996). 
There is some indirect information for nausea genesis from human studies where 
nausea was an associated or incidental finding however these studies are difficult to 
interpret as other symptoms such as acute pain act as confounding factors.  
The human studies specifically studying nausea genesis in the brain include a 1996 
magnetic source imaging study whereby one subject underwent yaw-axis rotations with 
side-to-side head movements and ipecac ingestion which led to the inferior frontal gyrus 
being activated (Miller et al., 1996). This activation was reversed when the same subject 
was administered the anti-emetic drug ondansetron, which is a 5-HT3 receptor 
antagonist. These results supported an older 1993 electro-encephalography study 
which demonstrated increased activity in the temporo-frontal region during motion 
sickness (Chelen et al., 1993). More recently, an fMRI study of visual motion induced 
nausea on 28 women discovered that there were also activation of the dorsolateral 
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prefrontal cortices bilaterally and in addition a broader network involving the 
interoceptive, limbic, somatosensory brain regions were also stimulated (Napadow et 
al., 2012b). Activation of the insula and cingulate cortices have also been shown to play 
an important role in animal and other related human studies (Stern et al., 2011). 
Previous studies have also shown there are important associated psychophysiological 
changes (e.g. anxiety), cardiac autonomic, gastric and hormonal activity during visual 
motion induced nausea and it is important to preselect the subjects who demonstrate 
these changes to ensure they are actually experiencing nausea as self-reporting is 
prone to bias (Stern et al., 2011).  
In short, as nausea increases in an individual they will demonstrate increasing levels of 
anxiety; sympathetic arousal and parasympathetic withdrawal; shift from normal gastric 
activity to abnormal activity that is predominantly tachygastric; and also an increase in 
vasopressin and cortisol (Figure 38). 
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Figure 38 Changes associated with visual motion induced nausea. There is increased 
anxiety; sympathetic arousal and parasympathetic withdrawal; shift from normal gastric 
activity to abnormal gastric activity that is predominantly tachygastric; and an increase 
in vasopressin and cortisol. 
 
It is thus recommended that a human model of nausea investigated by functional 
magnetic resonance imaging after carefully selecting a safe stimulus and the right 
subjects may shed light upon the brain processing of the poorly understood “personal 
experience” of nausea (Kowalski et al., 2006). 
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2 Developing a human model of nausea  
2.1 Developing a safe and reliable stimulus for studying nausea  
The first and most important criterion for a suitable stimulus would be safety as we are 
conducting non-therapeutic clinical research on human subjects according to the 
Declaration of Helsinki (Williams, 2008). This criterion was met in our studies with the 
stimulus inducing nausea in approximately half of the subjects and with the majority of 
them only reporting mild to moderate levels of nausea that resolved within 5 minutes of 
stopping the stimulus. In addition, even those subjects who experienced severe nausea 
felt safe enough and in control of the situation that they were able to complete all the 
studies as they were able to close their eyes whenever the stimulus proved to be too 
much. This prevented any retching or vomiting in our subjects for all the studies. 
Furthermore, none of the subjects reported any lasting effects after the studies when 
questioned up to a year after the studies. In fact, we were able to re-recruit 5 of the 
subjects for all three of the main phases of the study and 30 subjects for two main 
phases of the study.  
The visual motion induced nausea model in humans appears to be an effective and 
reproducible model with the caveat that habituation to the stimulus will occur at some 
point if the same subjects are repeatedly exposed to the stimulus (in our study it 
happened after the stimulus was presented for the 5th time) as reported in the literature 
(Bos et al., 2010). This model is also able to provoke the classical changes associated 
with nausea in the subjects who are susceptible more than the resistant subjects that 
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will help with subject selection for further fMRI studies but there are other considerations 
we should be mindful of that are discussed below. 
Visual motion induced nausea has the weakness (Muth et al., 1996, Gianaros et al., 
2001) that multiple sensation can be evoked that are described as central, peripheral, 
and sopite sensations (Gianaros et al., 2001). The sensation of nausea in our study was 
also moderately correlated with Spielberger state anxiety inventory (r=0.63, p<0.05) but 
this has been reported previously and expected as nausea causes general discomfort 
and is stressful (Burish and Carey, 1986, Haug et al., 2002). However, the 
psychophysiological responses to the nausea stimulus seen in our study are likely to be 
specific to the nausea induced because of only weak to moderate correlations were 
seen between the nausea scores and headache or STAI state anxiety scores. There 
were poor correlations between the nausea induced in our study with the STAI trait 
scores, other related motion sickness sensations, and neuroticism score.  
The motion video stimulus was also chosen for its safety profile and may not be 
generalizable for other nausea inducing stimuli although there is some evidence to 
suggest that susceptibility to nausea from motion sickness may potentially predict 
susceptibility to nausea in chemotherapy patients and physically-induced motion 
sickness (Golding, 2006). In terms of identifying a nausea stimulus that is adaptable for 
brain imaging, the visual motion induced nausea described in this studies is one of the 
most suitable stimulus currently available and it allows identification of subjects that are 
either susceptible and resistant (Stern et al., 2011). It would be advantageous for future 
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studies to explore the other possible stimuli for nausea induction and also to study 
nausea in patients with pre-existing medical condition or various drugs, however this 
may be fraught with difficulties as such stimuli would be difficult to predict and control 
and therefore may be unsafe in the brain imaging environment.  
 
2.2 Subjects selection for a fMRI human model of nausea 
Nausea is a “personal experience” with large variations between individuals (Stern et 
al., 2011). Thus, to ascertain that an individual is actually feeling nauseous it is 
necessary to be able to associate the nausea reports with objective psychophysiological 
changes. 
As the experience of nausea may be different in each individual, it would be ideal to 
remove these possible biases by using the same individual as their own controls. 
Furthermore, the individual variations to the responses of visual motion induced nausea 
can help us identify those who are more susceptible and those who are more resistant 
and the comparisons between the two may uncover important differences in how they 
process the stimulus that may explain the reasons for the differences observed. 
As seen in chapter 3, there is a widely spread variation in responses to the stimulus 
used in these studies but it was possible to identify 28 subjects who were susceptible 
(reporting moderate to severe nausea), 42 subjects who were resistant (with no nausea 
reported) and 28 subjects who were intermediate. The susceptible subjects showed the 
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classical changes associated with nausea with regards to the cardiac autonomic and 
gastric activity while the resistant subjects did not. These changes were not seen in the 
susceptible subjects during control video. Thus, it was possible to show that this model 
can be used to preselect suitable individuals before the study to allow for the best 
possible outcome during the fMRI studies.  
It is important to bear in mind that these volunteers may be self-selecting either because 
they know that they are relatively immune to the stimulus, or conversely because they 
are curious about the fact that they may be susceptible to the stimulus, or even because 
they consider it a sign of machismo (Stern et al., 2011). On top of that, the extent to 
which the decision to participate in the study is influenced by financial or other reward is 
not known. However, these issues are similar to those involved in recruiting humans for 
studies of pain (Langley et al., 2008). 
 
2.3 Adapting the stimulus for a fMRI human model of nausea 
I have demonstrated that the virtual reality stimulus can be adapted to the fMRI 
investigative environment with the pre-existing infrastructure without the need for 
complicated or expensive modifications to the MRI infrastructure (Napadow et al., 
2012a, Kowalski et al., 2006). Nausea is still effectively induced and the susceptible and 
resistant subjects still reported similar levels of nausea and anxiety (intra-class 
correlation coefficiency of moderate to good reproducibility) although less with MRI 
goggles video compared to the projected video in Chapter 3 due to a larger field of view 
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in projected videos (Bos et al., 2010). As these subjects have had their subjective 
reports of nausea validated by objective cardiac sympathetic arousal, parasympathetic 
withdrawal, shift of normal to dysrhythmic gastric myoelectrical activity, increased 
cortisol and increase state anxiety (refer Chapter 3), we are making the assumption that 
they are experiencing the same psychophysiological changes as described in chapter 3. 
It is also important in developing fMRI models that we design a control task (Iannetti and 
Wise, 2007) and the static cityscape without any motion used in our study appears to be 
a good control as this task still requires the subjects to perform all the usual visual tasks 
but without the development of nausea. The activation of visual areas of the brain in 
both motion and control video groups confirms that the two tasks were well matched for 
activation of the visual pathways.   
More detailed investigation using non-visual/vestibular stimuli to evoke nausea will be 
needed to determine if the brain processing of nausea is similar with different input 
pathways or if there are important differences that may potentially be important when 
thinking about treating the widely varying causes of nausea for the clinician. 
Investigating disease states associated with nausea may be a potential option such as 
cyclic vomiting syndrome (Olden and Chepyala, 2008) and migraine (Cuomo-Granston 
and Drummond, 2010). 
In this study, areas of the brainstem like the brainstem nuclei or the NTS that are 
postulated to play a key role in nausea pathways were not seen, however these 
medullary nuclei are at the limit of fMRI spatial resolution and are also susceptible to 
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cardiorespiratory artifacts. In future fMRI studies specifically targeting the brainstem 
using 3 Tesla MRIs for better spatial resolution or possibly complementary studies like 
high resolution research tomography (HRRT) that was recently shown to be able to 
quantify the serotonin transporter availability in the brainstem may be helpful in 
developing a better understanding of brain stem processing of nausea (Schain et al., 
2012). 
My study in chapter 5 demonstrated that the central effects of scopolamine may be 
investigated using the model of visual motion induced nausea. Unfortunately, the study 
also shows that subject preselection is likely necessary with the wide individual variation 
in the responses to scopolamine (Spinks et al., 2004). Thus future studies will need to 
preselect subjects who are susceptible to the nausea stimulus and subsequently 
preselect those who show scopolamine induced modulation of nausea and associated 
psychophysiological responses before studying them in the fMRI environment.  
In summary, these studies have advanced the development of a fMRI human model of 
nausea in several aspects, particularly with respects to a more versatile and easily 
adaptable stimulus and better subject preselection. 
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3 Mechanisms involved in visual motion induced nausea 
3.1 Prefrontal cortices 
These studies show that the inferior frontal gyrus was positively correlated with nausea 
and this activation may potentially be reversed with scopolamine. After scopolamine 
administration all the subjects as a group had significantly reduced bilateral inferior 
frontal gyrus activity. When placebo was compared with scopolamine brain activity, 
there was also a trend towards the bilateral inferior frontal gyrus becoming less active 
(post-hoc reanalysis of 5 subjects modulated by scopolamine with inferior frontal gyrus 
significantly inhibited bilaterally after lowering Bonferonni correction with cluster p value 
at p=0.05; Left and right cluster size 43 & 37; peak talairach coordinates x,y,z are -
36.11, 25.93, -9.90 & 25.28, 14.81, -9.90; p<0.02 & p<0.03). This appears to suggest 
that the inferior frontal gyrus plays an important role in the nausea pathway consistent 
with the previous studies (Napadow et al., 2012b, Bense et al., 2001, Fasold et al., 
2002, Denuelle et al., 2007, Miller et al., 1996). The prefrontal cortices may also play a 
role in spatial processing that may be important in visual motion induced nausea as a 
human study using a virtual reality version of the Morris Water Maze (well established 
spatial test in animals) showed there was medial and middle frontal gyrus activation 
during scopolamine with no inferior frontal gyrus activation seen (Antonova et al., 
2011a). This warrants further studies with more advanced technology for example the 
electro-encephalography with 3 Tesla or higher fMRI that has better temporal and 
spatial resolution (Iannetti and Wise, 2007). 
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3.2 Parahippocampus  
When comparing the brain activity between the motion video and control video for all 
subjects the left parahippocampus was inhibited in the motion video. Furthermore, the 
right parahippocampus activity was also decreased when comparing nausea 
susceptible and resistant subjects during the motion video. In addition, right 
parahippocampus activity decreased as nausea levels increased in susceptible 
subjects. Conversely, the left parahippocampus was activated in resistant subjects as a 
group during the motion video. There was also a trend of increased left 
parahippocampus activity after scopolamine administration versus after placebo in the 5 
scopolamine modulated subjects with a trend of decreased right parahippocampus 
activity. Thus it appears that the parahippocampus may play a role in the nausea 
pathway with scopolamine appearing to possibly modulate it however further work is 
needed to confirm this.  
It is possible to speculate that the parahippocampus is a pivotal area involved in the 
processing of the visual motion induced nausea in our subjects such that its inhibition 
signifies the disorientation induced by the stimulus leading to the sensory conflict 
(Reason and Brand, 1975) postulated to generate nausea. Interestingly the nausea 
resistant individuals as a group increased left parahippocampal activity that may confer 
some protection against disorientation that may be involved in the generation of nausea.  
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In this study, the hippocampus (left hippocampus, cluster size 3484, peak talairach 
coordinates (x=-28.89, y=-18.52, z=-9.90), p<0.0012) was also inhibited in all subjects 
during the motion video.  
There is evidence from both human (Aguirre et al., 1996, Epstein and Kanwisher, 1998, 
Ishai et al., 1999) and animal (Haley et al., 2011) studies suggesting that the 
parahippocampus and hippocampus play a role in orientation and navigation; and 
clinical lesions of the hippocampus and parahippocampus present with disorientation 
(Habib and Sirigu, 1987, Hublet and Demeurisse, 1992). There is also evidence that 
muscarinic receptors are present in high concentrations in the prefrontal cortex (PFC) 
and the hippocampus (Nathanson, 2008) and have an integral role in spatial learning 
and memory in rodents, nonhuman primates, and humans (Wisman et al., 2008, Gage 
et al., 1988, Fredrickson et al., 2008, Thomas et al., 2008). And scopolamine has been 
shown to modulate the hippocampus/parahippocampal gyrus and disrupt spatial 
orientation memory in the human brain by fMRI (Antonova et al., 2011b).  
Visual motion induced nausea starts from vection generating disorientation that 
develops into nausea and both worsen progressively with increasing exposure to the 
stimulus. My studies may possibly provide the first objective evidence of the brain 
pathways involved in the universally acknowledged and accepted sensory conflict 
theory initially proposed by (Reason and Brand, 1975) with the parahippocampus 
appearing to have a protective role against the development of visual motion induced 
nausea.  
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I have adapted a diagram with the proposed pathways of nausea generation to include 
the additional pathways in this study on the right with the possible interactions in red 
arrows (Figure 39). 
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Figure 39. Adapted diagram (Stern et al., 2011) summarizing major pathways involved 
in the sensation of nausea. The pathways shown combine Craig’s (2002) primate 
pathways involved in the processing of abdominal vagal afferent information; and 
projections of the area postrema and vestibular system (Loewy and Spyer, 1990, Yates 
et al., 1998, Saper, 2002) thus providing a pathway by which nausea could be induced 
by their activation. It also highlights the hierarchical information processing by shading 
brain structures with specific structures indicated with a dotted line (...). Second order 
projections with a dashed line (---) and higher order projections with a solid (__) line. 
The boxes on the right side indicate the additional pathways suggested by this study 
with the possible interactions in red arrows. Abbreviations: ANS-Autonomic Nervous 
System; AP-Area Postrema; BS-Brain Stem; H-Hypothalamus (particularly Posterior 
hypothalamus, supraoptic and paraventricular nuclei); I-Insular region of the Cerebral 
Cortex; NTS-Nucleus Tractus Solitarius; PO- Pons; Sa – Greater Splanchnic Nerve 
Afferent Fibres; SC-Spinal Cord; T-Thalamus; Va-Abdominal Vagal Afferent Nerves; 
Vestibular n.-Vestibular Nerve Nucleus; VII-Vestibular Nerve; VMb-The basal region of 
the ventromedial thalamic nucleus; Vmpo-The posterior region of the ventromedial 
nucleus of the thalamus. 
Inferior Frontal 
Gyrus 
Parahippocamp
Substantia 
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In summary, further studies with other types of nauseogenic stimuli and other 
pharmacological agents are now warranted to explore further the role of the prefrontal 
cortices and the parahippocampus in the genesis of nausea. New technologies with 
better temporal resolution like electro-encephalography with fMRI may possibly provide 
more answers.  
 	  
 193 
 
4 Conclusion 
Understanding the pathways involved in the genesis of visual motion induced nausea is 
clearly relevant to the identification of new treatments for patients suffering from motion 
induced nausea and it may also provide an important tool for quantitative 
pharmacological studies in the future. There are also more general implications as 
motion induced nausea susceptibility have been shown to predict susceptibility to post-
chemotherapy nausea. Thus, a better understanding of all pathways involved in visual 
motion induced nausea may provide a basis to recognise the mechanisms and treat 
successfully conditions in which nausea is induced through unknown or incompletely 
understood mechanisms. 
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